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List of Abbreviations 
 
a.a. 
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after activation 
antigen presenting cells 
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BM bone marrow 
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Summary 
 
The treatment of human arthritis and murine model of colitis with depleting CD4 antibodies 
leads to the significant amelioration of an established disease, arguing that CD4+T 
lymphocytes are a driving force and a relevant therapeutic target in chronic inflammatory 
diseases (Horneff et al. 1991; Brett et al. 1996; Emmrich et al. ; Brasseit et al. 2016). 
Nevertheless, the vast majority of CD4+ T lymphocytes residing in the inflamed tissue itself 
are neither proliferating, nor do they express effector cytokines (Firestein and Zvaifler 2002), 
except Interferon-. How do CD4+ T cells adapt their metabolism for survival in the inflamed 
tissue? In contrast to the activated T cells, memory T cells are more dependent on fatty acid 
oxidation for their maintenance (van der Windt and Pearce 2012; van der Windt et al. 2012; 
Buck et al. 2015; Pearce et al. 2009). At the same time, memory CD8 T cells synthesize fatty 
acids intracellularly from imported glucose (Sheriff et al. 1995; O'Sullivan et al. 2014), a 
mechanism to gain energy for cell longevity (Cui et a . 2015). This thesis describes analysis 
of the metabolism of CD4 T lymphocytes driving chronic inflammation and persisting at the 
site of inflammation, exemplified by cells that reside in the inflamed tissue of patients with the 
rheumatic disease juvenile idiopathic arthritis. To specifically take aim at the CD4+ T 
lymphocytes persisting at the site of inflammation, it is important to determine how these 
cells adapt their metabolism. We show that pathogenic CD4+ CD45RO+ PD1+ CXCR5- T 
cells that were isolated from the synovial fluid of patients with juvenile idiopathic arthritis are 
dependent on a fatty acid oxidation for survival ex vivo. Thei can be blocked by 
blocking FAO with Etomoxir, pointing to the option of targeting such cells by metabolic 
interference.  Furthermore, CD4+ CD45RO+ PD1+ CXCR5- T cells had upregulated 
expression of Twist1, a hallmark transcription facto  of T lymphocytes persisting in the 
inflamed tissues of patients with chronic-inflammatory diseases of joints or the gut (Niesner 
et al. 2008). Expression of Twist1 is specific for Th1 lymphocytes which have repeatedly 
been re-stimulated in vitro, or isolated from inflamed tissue (Niesner et al. 2008). This 
transcription factor dampens immunopathology caused by the T cells (Niesner et al. 2008), 
and supports their persistence, by inducing microRNA148a, which regulates expression of 
the proapoptotic protein Bim (Haftmann et al. 2015). Additionally, there is already evidence 
that Twist1 regulates metabolic processes. In myocytes Twist1 regulates glycogen storage 
and inflammation (Mudry et al. 2015a). In adipocytes, Twist1 st mula es fatty acid oxidation 
by inducing expression of Carnitine palmit yltransferase I (CPT1) mRNA, a key player of 
FAO (Pettersson et al. 2010; Dobrian 2012). This thesis shows, through conditional genetic 
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inactivation of Twist1 in CD4+ T lymphocytes, that Twist1 also regulates the metabolism of 
CD4 T lymphocytes of chronic inflammation, by downregulating glycolysis, promoting fatty 
acid synthesis and protecting the cells from ROS. Twist1 does so by downregulation of Myc 
and upregulation of the genes involved in mitochondrial biogenesis and fatty acid synthesis 
such as Atf5, Bnip3, Gpt2, Gpx4, Myc, Oxct1, Rdh11, Slc2a1, Slc2a3, Paics, Pfkp, and 
Ppp1r3b. Additionally we show that Twist1 deficient repeatedly reactivated murine Th1 cells 
are unable to survive on fatty acid oxidation and have increased levels of lipid peroxidation. 
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Zusammenfassung 
CD4+ T Lymphozyten spielen eine entscheidende Rolle bei chronisch entzündlichen 
Erkrankungen und stellen deshalb relevante therapeutische Ziele dar. So führt die 
Behandlung mit Antikörpern, die CD4+ Zellen depletieren, nicht nur zur Verbesserung der 
Symptome im murinen Colitis-Modell, sondern auch bei Patienten mit rheumatoider Arthritis 
(Horneff et al. 1991; Brett et al. 1996; Choy et al. ; Emmrich et al. ; Brasseit et al. 2016).  
Ein Großteil der CD4+ T Lympphozyten befindet sich direkt im entzündeten Gewebe, wobei 
die Zellen mit Ausnahme von Interferon- weder Effekt rzytokine ausschütten, noch 
proliferieren (Firestein and Zvaifler 2002). Es stellt sich die Frage, wie diese Zellen im 
entzündeten Gewebe überleben können und wie sie ihren Stoffwechsel an die dortigen 
Bedingungen anpassen. Im Gegensatz zu aktivierten T Zellen, basiert der Metabolismus von 
Gedächtnis T Zellen auf der Oxidation von Fettsäuren (van der Windt and Pearce 2012; van 
der Windt et al. 2012; Buck et al. 2015; Pearce et al. 2009). Die Fettsäuren werden dabei 
unter anderem intrazellulär aus Glucose synthetisiert, die zuvor aufgenommen wurde (Sheriff 
et al. 1995; O'Sullivan et al. 2014). Dieser Mechanismus ist gleichzeitig notwendig und 
ausreichend für die Langlebigkeit von CD8 T Zellen (Cui et al. 2015). 
Diese Arbeit beschreibt am Beispiel der Juvenilen Idiopathischen Arthritis (JIA) die Analyse 
des Stoffwechsels von CD4+ T Lymphozyten, die chronische Entzündungen antreiben und 
im entzündeten Gewebe lange Zeit persistieren. Pathogene CD4+ CD45RO+ PD1+ CXCR5- 
T Zellen wurden hierfür aus Synovialflüssigkeit von Patienten mit JIA isoliert und gezeigt, 
dass auch bei diesen Zellen der Stoffwechsel auf Fettsäureoxidation beruht. Wurde die 
Fettsäureoxidation durch Etomoxir blockiert, starben die Zellen. Die Störung des 
Stoffwechsels dieser Zellen könnte somit eine Option für einen neuen Therapieansatz 
darstellen. Zusätzlich war die Expression des Transkriptionsfaktors Twist 1 in diesen CD4+ 
CD45RO+ PD1+ CXCR5- T Zellen hochreguliert. Twist 1 ist ein Marker für T Lymphozyten, 
die in entzündetem Gewebe von Patienten mit chronisch-entzündlichen Erkrankungen der 
Gelenke oder des Darmes persistieren (Niesner et al. 2008). Untersuchung in vitro ergaben
außerdem, dass Twist 1 spezifisch von Th1 Lymphozyten exprimiert wird, die mehrfach re-
stimuliert wurden (Niesner et al. 2008). Dieser Transkriptionsfaktor wirkt einerseits der  
Gewebszerstörung, die von T Zellen verursacht wird, entgegen (Niesner et al. 2008), und 
unterstützt anderseits die Persistenz der Zellen im Gewebe durch die Induktion der 
microRNA148a, die die Expression des pro-apoptotischen Proteins Bim reguliert (Haftmann 
et al. 2015). Die Beteiligung von Twist 1 an der Regulation metabolischer Prozesse konnte 
Zusammenfassung 
 
9 
 
bereits nachgewiesen werden. In Myozytenbeeinflusst Twist 1 die Speicherung von 
Glycogen (Mudry et al. 2015a). In Adipozyten induziert Twist 1 die Expression von Carnitine 
palmitoyltransferase I (CPT1) mRNA, einem Schlüsselenzym der Fettsäureoxidation. 
Außerdem stimuliert Twist 1 die Fettsäureoxidation (Pe ersson et l. 2010; Dobrian 2012).  
In dieser Arbeit zeigen wir durch die konditionelle genetische Inaktivierung von Twist 1 in 
CD4+ T Lymphozyten, dessen Einfluss auf die Regulation des Metabolismus von CD4+ T 
Lymphozyten bei chronischen Entzündungen. Dabei wird die Glycolyse verringert und 
vermehrt Fettsäuren synthetisiert, um die Zellen vor reaktiven oxidierenden Spezies (ROS) 
zu schützen. Twist 1 reguliert die Expression von Myc herab und fördert die vermehrte 
Expression von Genen, die in die mitochondriale B ogenese und Fettsäuresynthese involviert 
sind: Atf5, Bnip3, Gpt2, Gpx4, Myc, Oxct1, Rdh11, Slc2a1, Slc2a3, Paics, Pfkp, and 
Ppp1r3b. Zusätzlich konnten wir nachweisen, dass mehrfach re-stimulierte, Twist-defiziente 
Th1 Zellen unfähig sind, durch Fettsäureoxydation zu überleben, sondern den Stoffwechsel 
auf Lipid-Peroxidierung umstellen. 
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 Introduction 
 
1.1 Adaptive immunity  
Recombinatorial rearrangement of different immunoglobulin or T cell receptor gene (TCR) 
segments is common to all jawed vertebrates. It gives rise to an antigen receptor repertoire 
that is unique for each and every lymphocyte. After recognition of their specific peptide, 
lymphocytes respond by clonal amplification, cellular differentiation and production of 
antibodies to combat pathogens.  Importantly, after antigen clearance, a subset of 
lymphocytes survives to become memory cells. M mory cells are capable of a highly specific 
recall reaction allowing fast clearance upon re-encounter of the antigen. The lymphocyte 
population consists of two major subsets, B-and T- cells, tha  develop from bone-marrow 
derived hematopoietic progenitor cells, which mature in a bone marrow (Cooper 2015) and a 
thymus (Shah and Zuniga-Pflucker 2014), respectively. Lymphocytes are distinguished by 
structurally variable antigen receptors:  B-cell antigen receptor (BCR) is formed by the same 
genes that encode antibodies, class of proteins called immunoglobulins(Ig). The focus of this 
thesis is cells expressing T cell antigen receptor (TCR), described further. 
 
1.1.1  T cell receptor formation 
 
The T cell receptor (TCR) is generated by random non-homologous DNA recombination of V, 
D and J gene segments during T- cell development in the thymus. Combinatorial and 
junctional diversity together with a combination of variable chains gives rise to approximately 
1018 unique TCRs (Davis and Bjorkman 1988) that become DNA imprinted, allowing clonal 
expansion of identical cell clones. The maturation of T cells in the thymus leads to the 
expression of CD3. During the following positive selection T cells that recognize self MHC 
class I (expressed by all nucleated cells) or II (expressed exclusively on antigen presenting 
cells) with low avidity are preserved and subsequently express cluster of differentiation (CD) 
8+ or CD4+, named cytotoxic T cells (Tc) also called T helper cells (Th), respectively. In the 
course of the negative selection that follows, cells that strongly bind self-peptide in the 
context of self-MHC are deleted via induction of apoptosis (Carpenter and Bosselut 2010) or 
become anergic within the thymus to prevent autoimmunity (Abbas et al. 2007; Germain 
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2002; Spits 2002). The resulting mature T cell repertoire is tolerant to self-antigens, 
nevertheless some of the T cells that recognize self-antigen with intermediate avidity are not 
deleted but become natural T regulatory (nTreg) cells, which have the ability to suppress 
effector T cell function (Hsieh et al. 2012; Liston et al. 2008). In some cases auto-reactive 
cells escape these mechanisms and can become, in om ination with environmental factors, 
activated in the periphery leading to development of autoimmune diseases, which is the 
subject of this thesis and discussed in more detail in section 1.3.   
1.1.2  Activation of T cell via T-cell receptor 
 
Mature but naïve T cells leave the thymus and migrate through the SLO (secondary lymphoid 
organs such as lymph nodes, spleen, tonsils or mucosa-ass ciated lymphatic tissue) and 
periphery until they encounter TCR respondent antigen displayed by professional antigen-
presenting cells (APCs). APCs are comprised of the innate immune system cells, such as 
dendritic cells (DC) and macrophages but also cells of the ad ptive immune system, such as 
B cells. After a pathogen is captured by an APC and processed in endo-lysosomal 
compartments (Abbas et al. 2007; Gao et al. 2002; Lustgarten et al. 1991), the APCs migrate 
along the lymphatics into the T cell zone of the local SLO where they express peptide-MHC 
molecules binding to TCR together with co-stimulatory molecules such as B7-1 (CD80) and 
B7-2 (CD86) that are binding to CD28 receptors on T cells. Signalling complex is further 
stabilized by expression of adhesion molecules, such as leukocyte function-associated 
antigen-1 (LFA-1) binding to intercellular adhesion molecule-1 (ICAM-1), expressed on the 
surface of APCs (Huppa and Davis 2003). Timing and duration of signals from surface 
inhibitory molecules, like cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and 
programmed cell death protein 1 (PD-1), or stimulatory signals, such as inducible T cell co-
stimulator ICOS, influence signalling outcome. TCR triggering without co-stimulation or 
provision of cytokine signal without TCR stimulus results in T cell anergy (Jenkins and 
Schwartz 1987; Sckisel et al. 2015). After the successful activation, an intracellular signalling 
is propagated via the cytosolic region of the TCR. Triggering intracellular activation cascade 
(Abbas et al. 2007) leads to a burst-like release of Ca2++  into cytos l from its stores in the 
Endoplasmic Reticulum (ER). Calcium release is followed up by expression of canonical 
transcription factors such as nuclear factor-κB (NF- κB), activator p otein 1 (AP-1) and 
nuclear factor of activated T cells (NFAT). Those factors play in concert with effects of co-
stimulatory signalling initiated by CD28 engagement leading to upregulation of the 
phosphoinositide 3- kinase (PI3K) pathway leading to an activation phenotype (Okkenhaug 
et al. 2004). Activated cells decrease expression of surface molecules, such as CCR7, and 
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CD62L, which are SLO localization signals, and up-regulate molecules, such as LFA-1 or 
CD99 that allow them to emigrate to the site of inflammation via transendothelial migration 
(Muller 2013). Activated cells express Interleukin 2 receptor-α chain (CD25), which allows 
them to react to the growth promoting cytokine IL2 (Iezzi et al.). Clonally expanding T cells 
activate B cells, macrophages and dendritic cells triggering activation of adjacent 
inflammatory cells.  
 
1.1.3  Differentiation of effector T cells 
Post-activation T cell function is defined primarily by express on of a cluster of differentiation 
(CD) surface molecules. CD8+ T cells specifically eliminate pathogen-infected host cells by 
cytotoxic means. Meanwhile, CD4+ T cells provide co-stimulatory signals and generate 
cytokines and chemokines. Cytokines and chemokines provide pr liferative and activation 
signals to neighbour cells, such as CD8+ T cells, B cells (production of antigen-specific 
antibodies) or macrophages to perform specific functions or recruit new immune cell subsets 
to the site of inflection. Cytokine milieu, type and duration of TCR engagement, type of APC, 
nutrient availability and surrounding cells are main factors dictating cell differentiation into a 
distinct T helper subsets (van Panhuys et al. 2014; van der Windt and Pearce 2012). T 
helper subsets are defined by expression of a master tra scription factor, set of cytokines 
and functions. Apart from the main recognized subsets ( 
Figure 1-1) it is becoming clear that the factors determining phenotype are complex and that 
there exist number of phenotypically and functionally f exible T helper subsets (Hegazy et al. 
2010; Abromson-Leeman et al. 2009; Sakuraba et al. 2009) that are not falling to any 
established category (Becattini et al. 2015; Hirahara and Nakayama 2016). 
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Figure 1-1: T helper subsets: 
Depending on the cytokine environment produced by APCs, T helper subsets express exclusive 
master transcription factors, produce distinguishable cytokines and are involved in distinct immune 
functions 
1.1.4 Effector T helper 1 cells (Th1)  
 
Differentiation into the Th1 lineage is characterized by expre sion of the master transcription 
factor T-bet. T-bet expression is induced in two waves: first by TCR engagement in the 
presence of IFN-γ that activates STAT1, followed with a second wave of antigen-
independent regulation by IL-12, signal that induces STAT4 (Szabo et al. 2000; Schulz et al. 
2009; Mullen et al. 2001; Afkarian et al. 2002; Lighvani et al. 2001). T-bet upregulates the 
transcription of IL-12Rß2 and IFN-γ and therefore drives an auto-regulatory positive 
feedback-loop (Chang and Aune 2005; Schulz et al. 2009). Additionally, expression of T-bet, 
directly and indirectly, represses genes of other T helper subsets to stabilize the Th1 fate 
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(Lazarevic and Glimcher 2011; Szabo et al. 2000; Hwang et al. 2005; Djuretic et al. 2007; 
Naoe et al. 2007). IFN-γ is considered to be a signature cytokine for the Th1 subset 
(Mosmann et al. 1986; Szabo et al. 2002) and together with the secretion of IL-2 and TNF-α 
it facilitates immune responses of cytotoxic T cells and macrophages against intracellular 
viral or bacterial pathogens as well as tumour cells. Additionally, Th1 cells support B cells to 
secret high-affinity pathogen-specific antibodies. Th1 cells are able to produce IL10, a 
cytokine with a broad spectrum of anti-inflammatory functions, which are essential as a 
negative feedback mechanism in the self-limitation of inflammatory responses (Saraiva et al. 
2009). IL10 regulates T cell responses by inhibition of MHC class II and co-stimulatory 
molecule B7-1/B7-2 expression on monocytes and macrophages. Also, IL-10 limits the 
production of pro-inflammatory cytokines such as IL-1, IL-6, IL-12, IL-18, TNF  and various 
chemokines (Couper et al. 2008). IL-10 can also act directly on CD4 T cells, inhibiting 
proliferation and production of IL-2, IFN-γ, IL-4, IL-5 and TNF. Several factors, including IL-
27 (Anderson et al. 2009), IL-12 (Chang et al. 2007), TGF-β (Xu et al. 2009) or the Notch 
pathway (Rutz et al. 2008) induce IL10 expression from effector T cells. The transcriptional 
regulation of IL10 is still not fully understood, but Blimp1 has been shown to induce IL10 
expression in Th1 cells in a STAT4 dependent manner (Neumann et al. 2014), while AhR 
directly acts on  IL-10 expression in Th1 phenotypically related Tr1 cells (Mascanfroni et al. 
2015). 
1.1.5  Memory Th1 cells  
The elimination of the antigen and the ensuing reduction of survival factors, as well as 
intrinsic inhibitory pathways, l mit the magnitude and duration of the immune response. In the 
end, T cell responses decline and the population contracts through apoptosis. A small 
fraction of cells that survive the activation-induced stress (such as exposure to ROS) or 
metabolic exhaustion become memory T cells. Upon re-exposure to the same pathogen, 
memory cells can swiftly clonally expand and ear the antigen. The exact mechanisms of 
Th1 memory subset formation are still under investigation. At the peak of the primary Th1 
response the cell population is heterogeneous. Fate decision to become memory or short-
lived effector cell lies in the early expressionof the IL2 receptor CD25 (Pepper et al. 2011). 
When CD25 is expressed, IL2 binding activates STAT5 that induces expression of IL2RB, T-
bet, and Blimp1. Cells express low amounts of Bcl6 and downregulate CXCR5, becoming 
effector T cells. If CD25 is low, Bcl6 is upregulated, T-bet is transiently downregulated and 
CXCR5-positive population is formed. This population (about 25%) highly resembles the 
follicular T helper cells (TFH ). If cells have low expression of PD1, they will become memory 
Th1 cells (though some plasticity is retained). If ells retain high PD1 expression, they 
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become TFH  cells (Pepper et al. 2011). In a different study, a persistently stimulated 
population of memory CD4 Th1 cells in Mycobacterium tuberculosis - infected animals was 
heterogeneous and expressed either KLRG1 or PD-1. Even though KLRG1+ cells express 
high levels of cytokines in comparison to PD1+ cells, they are short-lived and proliferate 
poorly. Instead, PD1+ cells express fewer cytokines, retain plasticity and are able to survive 
longer. Even if this population of PD1+ cells shares ma y features wit  follicular helper cells, 
unlike follicular helper cells, these cells are capable of mounting enormous cytokine 
response (Reiley et al. 2010). 
 
1.2 Metabolism of T cell 
 
1.2.1 Metabolism during T cell activation 
 
Main metabolic pathways in the cell are depicted in Figure 1-2. During thymus maturation, 
cells undergo several metabolic switches. Mature naive T cells are maintained by IL-7 that 
supports homeostatic proliferation and survival (Schluns et al. 2000). IL-7 also supports 
employment of the oxidative phosphorylation, that is fuelled by catabolic metabolism of fatty 
acids, glutamine, and glucose (Pearce and Pearce 2013). Upon activation, cytosolic Ca2+ 
released from the ER induces mitochondrial enzymes such as pyruvate dehydrogenase 
(PDH), an enzyme that catalyse the entrance ofglucose-derived pyruvate into the TCA cycle 
in mitochondria. This initial metabolic phase is necessary for initiation of rapid cell expansion 
(Sena et al. 2013), during which demand for organelle biosynthesis and synthesis of effector 
and signalling molecules increases. Increase in oxidative phosphorylation comes together 
with high levels of reactive oxygen (ROS), produced by the electron transport chain. Next to 
oxidative phosphorylation, the second most important source of ROS (i.e., hydrogen 
peroxide and superoxide anion production) is NADPH de endent oxidase NOX5 (D'Autreaux 
and Toledano 2007; Winterbourn 2008). ROS are necessary for proper cell activation, 
signalling and T cell function (MacIver et al. 2013; Pearce et al. 2009; Wang et al. 2011). 
However, if ROS are not scavenged in a timely manner, they have a detrimental impact on 
the organism. Short-lived oxygen-containing molecules have high chemica  reactivity towards 
DNA, lipids and lipoproteins (Marnett 2002), potentially leading to apoptosis. Conversion of 
reduced glutathione to its oxidized form by ROS with H2O as a byproduct is one of the main 
mechanisms of ROS scavenging and release of oxidativ stress, mediated by glutathione 
peroxidases. One of its major family members, Gpx4, functions as a repressor of 12/15-
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lipoxygenase–induced lipid peroxidation (Seiler et al. 2008). It catalyses the reduction of lipid 
peroxide at the expense of reduced glutathione (Yang et al. 2014). NADPH has the ability to 
serve as a principal reductant of oxidized gluta hione n the cell. Oxidized glutathione is 
generated during scavenging reactions by Gpx4 (further discussed in 1.3.4). 
Biomolecule precursors to fuel cytokine release and proliferation are supplied largely by 
upregulation of glucose uptake and glycolysis, processes regulated downstream of 
activation- induced TCR signalling. TCR and CD28 engagement mediates an up-regulation 
of Akt and phosphoinositide 3-kinase (PI3K) pathway signalling that in the presence of IL-2 
lead to activation of mammalian target of r pamycin (mTOR). mTOR is a conserved 
serine/threonine kinase that plays a crucial role in the control of cell fate decisions both in the 
steady and activated state. mTOR serves as a node to coordinate signalling, metabolic and 
migratory pathways (MacIver et al. 2013). During activation, mTOR promotes lipid and 
protein synthesis, and importantly promotes upregulation of transcri tion factor hypoxia- 
inducible factor (HIF1- α) and Myc. HIF1-α is stabilized by low oxygen levels but stabilization 
also occurs under normoxic conditions in response to T- cell activation via STAT3 signals 
that are integrated by mTOR pathway, promoting its stability (Dang et al. 2011). Myc and 
HIF1-α upregulate genes involved in glycolysis and glucose uptake such as Glut-1, 
phosphofructokinase 1, hexokinase, pyruvate kinase or lactate dehydrogenases (Doedens et 
al. 2013; Wang et al. 2011; Finlay et al. 2012; Frauwirth et al. 2002), resulting in an increase 
in glucose uptake and catabolic metabolism (Maciver et al. 2008). These transcriptional 
events are leading to the initiation of a fast process called aerobic glycolysis, also named 
Warburg effect (Warburg et al. 1958). It provides cells with energetically inefficient (2 
molecules of ATP per molecule of glucose), but rapid and macromolecule rich metabolic 
resource that supplies cellular replication and new organelles. As a result, cells produce 
large amounts of lactate, responsible for acidification of the cellular outer space. Failure of T 
cells to increase glucose and glutamine uptake and metabolism via the PI3K/ Akt/ mTOR/ 
Myc/ HIF1-α pathway results in decreased survival, cytokine secretion and cytokine 
production (Michalek et al. 2011; Yaqoob and Calder 1997; Chang et al. 2013). An important 
aspect of glycolysis is the role of glycolytic nzyme glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) in cytokine regulation during T cell activation. It was shown in Th1 
cells that GAPDH binds to mRNA encoding IFN-γ, repressing its translation. As soon as 
glycolysis is triggered, inhibitory GAPDH is dissociated from the IFN-γ promoter and IFN-γ is 
highly expressed (Chang et al. 2013). Activation of TCR boosts also uptake of alternative 
carbon sources, most notably glutamine (Levring et al. 2012). Glutamine derived α-
ketoglutarate is incorporated into the TCA cycle by an enzyme α-ketoglutarate 
dehydrogenase (KGDH), which is upregulated upon activation by increased calcium influx. 
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TCA generates principle electron donors FADH2, NADH, and NAD+ in the TCA cycle, 
supplying to the electron transport chain that isfuelling OXPHOS. Glutamine contribution to 
TCA also supports the biosynthesis of polyamines and fatty acids. Fatty acids are formed 
from TCA cycle intermediates and NADPH molecules derived from the pentose phosphate 
pathway in anaplerosis process called fatty acid synthesis (FAS). Fatty acids can be further 
processed to form cholesterol that is used for membrane build-up during proliferation, 
phospholipids used as cell signalling molecules or epigenetic modification marks. Fatty acids 
can be stored in a form of triglycerides (Chou et al. 2013) and be oxidized to form energy 
during periods of quiescence (Pearce et al. 2013). It is established, that synthesis and 
maintenance of cellular lipid levels permit rapid membrane biogenesis and cell cycle 
progression, survival and effector function (Kidani et al. 2013), but the molecular pathways 
underlying these processes remain poorly defined. FAS has been shown to be regulated 
coordinately by activation-induced bHLH transcription factors mTOR, c-Myc (Wang et al. 
2011) and PPAR (Grygiel-Gorniak 2014) in T cells. Following activation, Myc and mTOR 
coordinate SREBP bHLH transcription factors (Kidani et al. 2013) that regulate lipid storage 
through regulation of glycolytic and lipogenic enzymes, such as hexokinase, fatty acid 
synthase and most importantly, Acetyl-CoA carbox lase (ACC) (H rton et al. 2002). ACC 
converts Acetyl-CoA into Malonyl-CoA, a precurs r in the synthesis of fatty acids in TCA. 
Malonyl-CoA provides the two-carbon building blocks that are used to create larger fatty 
acids by condensation with Acetyl- CoA, NADPH dependent reaction catalyzed by fatty acid 
synthase (FASN). Glucose alone stimulates lipid genesis by stimulation of hexokinase 
expression, fatty acid synthase and ACC-2 protei s (Guillet-Deniau et al. 2004). 
Subsequently, an elevated flux of glucose into the cell leads to an increased de ovo 
lipogenesis with triglyceride accumulation (Visiedo et al. 2013).  
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Figure 1-2. Mayor metabolic pathways in the cell. 
Adapted from (Buck et al. 2015) 
 
1.2.2  Metabolism of resting T cells  
 
During an activation-induced fatty acid synthesis in effector T cells, production of Malonyl-
CoA inhibits fatty acid oxidation (Hopkins et al. 2003). When an antigen is cleared, most 
effector T cells die, leaving behind only a small population of memory T cells that need to 
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survive long periods of quiescence. During this phase, the splicing variant of Bnip3 has been 
shown to promote mitophagy that supports the formation of memory (O'Sullivan et al. 2015; 
Gang et al. 2015) while protecting against oxidative stre s (Chinnadurai et al. 2008).  
Memory T cells in many ways resemble naive T cells but differences have been shown. In 
terms of biological function, it has been suggested that levels of spare respiratory capacity 
(SRC) and mitochondrial mass are higher in CD8 memory T cells (van der Windt et al. 2012), 
providing the extra energy storage to promote long-term survival and flexibility to use diverse 
substrates for energy generation, such as the oxidation of fatty acids. Bigger the 
mitochondria with higher SRC, bigger the ability of memory cells to simultaneously 
synthesize and oxidize fatty acids and therefore maintain mitoch ndrial fitness for a oxidative 
production of ATP in times of stress and metabolic deprivation. High SRC is a phenotypic 
trait connected to the longevity and the ability to robustly expand upon antigen stimulation 
(Pearce et al. 2009; van der Windt et al. 2012; van der Windt et al. 2013).  Understanding the 
regulation of FAO is still in the beginning stages. AMPK signaling has been shown to be 
crucial in a metabolic regulation of CD8 memory generation (Rolf et al. 2013), suppressing 
mTOR signaling (MacIver et al. 2013). AMPK signaling serves as an energy stress sensor 
that is increased by a change in intracellular AMP to ATP concentration. AMPK induces 
CPT1 expression (van der Windt and Pearce 2012), possibly in a peroxisome proliferator 
activated receptor (PPAR) gamma coactivator (PGC)-1 dependent mechanism, as 
demonstrated in muscle cells (Jager et al. 2007; Lee et al. 2006).  AMPK also 
phosphorylates and inhibits ACC, a crucial enzyme for production Malonyl-CoA. Low levels 
of Malonyl-CoA  release inhibition of Carnitine palmitoyl transferase 1a (CPT1) facilitating 
fatty acid oxidation (Jones and Thompson 2007). Furthermore, regulation of fatty acid 
oxidation by the PD-1 receptor engagement has been shown (Patsoukis et al. 2015). PD1 
engagement by PD1-L induces a decrease in aerobic glycolysis and enhances FAO in 
activated T cells. Such metabolic switch is mediated via increased expression of CPT1A 
together with upregulation of TAG hydrolase desnutrin/a ipocyte triglyceride lipase (ATGL), 
inducing lipolysis (Patsoukis et al. 2015).  Currently, the source of fatty acids for oxidation in 
T memory cells is debated and probably might be a distinguishing feature in metabolic cell 
phenotypes. CD8 memory T cells have been found to be unable to uptake fatty acids from 
their extracellular environment as effector T c lls do, and are dependent on intracellularly de 
novo synthesis of fatty acids, where glucose serves as one of the important sources for fatty 
acid synthesis (Weinberg and Chandel 2014; O'Sullivan et al. 2014). Surprisingly, at the 
same time, fatty acids are accessed for oxidation, a parallel and opposing process called a 
“futile cycle” (Weinberg and Chandel 2014). While the futility of T cell memory is just an 
emerging concept, it has been shown that a driving factor in futility (cycling of substrates 
between de novo lipogenesis and lipid oxidation) is the hormone leptin (Dulloo et al. 2004). 
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Leptin is produced by adipocytes and has been shown to be increasingly present in inflamed 
joints of arthritic patients, where its levels are correlated with disease activity. Leptin 
modulation of AMPK/ acetyl-CoA carboxylase (ACC) and mTOR/ ribosomal S6 Kinase was 
indicated in the process (Tian et al. 2014).  
Formation of triacylglycerol from activation induced glucose uptake is consistent with the 
critical role of Notch as a mediator of glucose uptake, for memory T cell survival (Maekawa et 
al. 2015). Further evidence for intracellularly accessed fat storage in memory T cells also 
comes from observation that LAL, enzyme hydrolyzing  choleste  esters and triacylglycerol 
to generate free FA (Sheriff et al. 1995) is highly expressed in CD8 memory T cells, while 
CD36, the main fatty acid uptake molecule is downregulated in memory T cells, in contrast to 
their effector counterparts (Sheriff et al. 1995) and that intracellular TAG synthesis supports 
cell longevity (Cui et al. 2015). Of note, most of the T cell metabolic studies described deal 
with CD8 T cells metabolism, while CD4 metabolism still remains not explored. 
 
1.2.3 T cell differentiation is associated with distinct metabolic pathways 
Metabolism influences the T cell phenotype by modulating both lineage-specific 
differentiation and cytokine production. A simplified view that glycolysis leads to the more 
inflammatory phenotype of effector cells, while oxidative phosphorylation and FAO is 
connected with non-inflammatory cells of T-reg and TFH  (Pearce and Pearce 2013; Michalek 
et al. 2011) is challenged by recent research showing high metabolic flexibility among cell 
types. Conventional T cells are activated and even are capable of limited proliferation when 
aerobic glycolysis is limited, as they will switch to OXPHOS (Chang et al. 2013; Sena et al. 
2013) and T effector cells still exhibit a substantial rate of FAO upon activation (Michalek et 
al. 2011).  Example of such divergence has been shown in metabolic regulation of cell fate 
of Th17 versus T-reg population.  In Th17 cells HIF1-α, the promoter of glycolysis, binds and 
activates RORγ-t, simultaneously attenuating development of T-reg cells by binding FoxP3 
and targeting it for proteasomal degradation (Dang et al. 2011). Accordingly, T-reg cells 
were considered to be a cell type-dependent solely on fatty acid oxidation, as in vitro 
blockade of CPT1a disrupts T- reg generation, while supplementation with fatty acids in vitro 
supports T- reg differentiation and function (Berod et al. 2014; Michalek et al. 2011). 
However, recently it was shown that transient expression of glycolysis enzyme Enolase-1 is 
critical for the induction of potent iT-regs from conventional T cells, even if a long-term 
expression of Enolase 1 can become detrimental (De Rosa et al. 2015), pointing to a 
complex metabolic phenotype of not only T-reg cells but probably also of other cell 
phenotypes. Bcl6, lineage-defining transcription factor of TFH , suppresses several glycolysis 
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genes potentiated by c-Myc and HIF1-α expression in Th1 cells (Oestreich et al. 2014), 
which are reliant in survival and effector function on glycolysis (Michalek et al. 2011; Chang 
et al. 2013). T-box transcription factor T-bet is required for IL2-STAT5 dependent increase of 
glycolytic enzyme expression (Oestreich et al. 2014) while it also antagonizes Bcl6 mediated 
gene repression of genes encoding molecules in the glycolysis pathway by direct interaction 
with its DNA binding domain. 
1.3 Rheumatic disease 
 
Juvenile idiopathic arthritis (JIA) is the rheumatoid disease (RD), which is closely related to 
another chronic autoimmune pathology Rheumatoid arthritis (RA) nd other diseases such 
as psoriasis arthritis (PsA), ankylosing spondylitis (AS) or Sjögre ’  disease (SD) (Yildirim et 
al. 2012). JIA is a highly heterogeneous disease encompassing arthritis that lasts at least 6 
weeks with onset before the age of 16 years (Ravelli and Martini 2007). JIA has several 
phenotypically and genetically distinct subtypes (Giancane et al. 2016) and unified diagnosis 
is still under debate (Martini 2012). Rheumatic joint inflammation presents itself by a 
formation of a thick multilayered granulation tissue in the joint, termed pannus, which is 
affecting tendons, cartilage and bone resulting in progressive joint and soft tissue 
destruction. In RA, shortened life expectancy is associated with increased cardiovascular 
risk, metabolic syndrome, psychosocial deficitincluding psych atric disease, osteoporosis, 
and increased cancer rates (Malmstrom et al. 2017). The e iology of rheumatoid diseases is 
highly complex and not fully elucidated. However, genetic factors, leading to a break in 
peripheral tolerance during thymus T cell maturation, are considered as a prerequisite to its 
early development (van der Woude et al. 2009). Several genetic alterations have been 
discovered to be associated with increased risk for arthritic synovial inflammation: well known 
genetic alterations is to the gene coding for the MHC class II molecule human leukocyte 
antigen D related (HLA-DR) on chromosome 6. Every clinical subtype of JIA is associated 
with distinct set of HLA haplotype, but RA has been associated with haplotypes HLA DRB1 
and HLA DRB4. Some of the other contributing mutations are: single nucleotide 
polymorphisms in the genes encoding for protein tyrosine phosphatase non-receptor type 22 
(van Oene et al. 2005; Pierer et al. 2006), or single polymorphisms found in the gene 
encoding programmed death-1 (PD-1). Resulting alterations in the activity of proteins lead to 
a decreased elimination of autoreactive T cells (Lin et al. 2004; Prokunina et al. 2004). 
Autoreactive T cells become increasingly present in the periphery while T-reg cell numbers 
decrease (Filion et al. 1995; Villoslada et al. 2001; Danke et al. 2004). Additionally, 
polymorphisms of the macrophage-resistance gene NRAMP1 that regulates activation of 
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macrophages for enhanced expression of tumor necrosis factor (TNF)-α, IL1-β and MHC 
class II, shared between RA and JIA patients might contribute to the development of the 
disease (Sanjeevi et al. 2000). Polymorphisms in PADI4 enzyme that are together with 
smoking responsible for the posttranslational conver ion of arg nine residues into citrulline 
have been found in both RA and JIA patients (Hisa et al. 2017).  Citrullination is thought to 
improve the fit in HLA alleles (Huizinga et a . 2005) and results in antibodies against post-
translationally citrullinated protein epitopes (ACPAs) (Kokk nen et al. 2011; Klareskog et al. 
2006; Kocijan et al. 2013). In some cases, antibodies against the Fc portion of IgG 
(“rheumatoid factor”) can be detected. Disease outbreak often begins with a triggering event, 
which is often a bacterial or viral infection with generally subclinical symptoms (Lang et al. 
2002; Zipris et al. 2005). 
 
1.3.1 Chronically stimulated CD4+ T cells in Rheumatoid Arthritis 
 
Histological staining of an inflamed synovial tissue reveals follicu ar lymphoid-like structures 
resembling germinal centres of lymphoid organs. These aggregates are rich in T cells, B 
cells expressing MHC class II, and dendritic cells (Simon et al. 1994). CD4+ T cells st 
prominent lymphocytic cell type infiltrating the inflamed synov um (Panayi et al. 1992). 
Physiologically, memory T cells that recognize pathogenic antigens provide the organism 
with long-lasting protection against recurrent infections. However, in the case of rheumatoid 
disease T cell longevity and the persistent effector response to autoantigens becomes 
detrimental. The important role of CD4+ T helper cells in autoimmune pathology is well 
demonstrated in depletion studies of T helper cell  in murine models of autoimmune arthritis 
(Hom et al. 1988; Ranges et al. 1985).  CD4+ T cells are initially activated by cognate 
cartilage antigen, citrullinated peptides or TCR independ n  pro-inflammatory cytokines that 
are secreted by neighbouring cells (Sattler et al. ; Zhang et al. ; Brennan et al. 2002; 
Burkhardt et al. 2006; Huizinga et al. 2005). Past or continuous antigenic stimulation is 
reflected in a CD45RO+ CD45RB - memory phenotype of ex vivo isolated CD4+ T cells. 
Further, the inflammatory and invasive rheumatoid arthritis synovial tissue is characterized 
by elevated levels of inflammatory T-helper cell 1 (Th1) cytokines such as IL-1β and TNFα 
(Feldmann et al. 2001), although the presence and inflammatory role of Th17 cells are also 
debated (Koenders et al. 2006). Transcriptionally, T cells isolated from synovial fluid of 
rheumatoid arthritis patient’s express high levels of the transcription factor TWIST1, a 
hallmark of repeated stimulation of Th1 cell´s TCR receptor (Niesner et al.).T wist1 also 
contributes to the survival and persistence of CD4+ T cells that are perpetrating synovial 
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inflammation (James et al. 2014; Firestein 2003; Haftmann et al. 2015). Other contributing 
factors to the survival, such as the inflammatory milieu (Cope 2002). CD4+ T helper cells 
were also found to be hypo-responsive to TCR stimulation in inflamed tissues (Reyes et al.), 
to which contributes chronic stimulation and high levels of oxidants at the site of inflammation 
(Maurice et al. ; Bao et al.). Hyporesponsiveness of sy ovial CD4+ T cells is reflected in 
downregulation of CD28 (Ammirati et al. ; Baniyash ; Zhang et al. ; Cope 2002) and by 
expression of negative regulators of co-stimulati n such as CTLA-1 or programmed cell 
death 1 (PD-1) (Li et al. 2014; Wan et al. 2006). PD1 is a key inhibitory cell-surface receptor 
of the CD28 superfamily that triggers pathways to attenuate T-cell responses and promote T-
cell tolerance. Rao et al has shown that an expanded population of CD4+ T cells, isolated 
from synovial fluid of patients with rheumatoid disease express PD1+, secrete IFN-γ and 
IL21 and is CXCR5-, therefore are not typical follicular helper cells but are capable 
pathogenic B cell instruction to secrete auto-antibodies and therefore are considered as 
pathogenic memory T cells (Rao et al. 2017b). 
1.3.2 Metabolism of autoimmune cells 
 
Due to their longevity and persistent memory response, pathogenic autoimmune T cells 
require a strategy for long-lasting energy supply. The metabolic pathways by which CD4+ T 
cells gain their energy are expected to display unique survival and energetic signatures. 
Metabolic adaptation of rheumatic synovial T cells has not been studied so far. In 2016  
Weyand and colleagues were able to show that naive CD4+ T cells from RA patients’ blood 
have a defect in the key glycolytic enzyme PFKFB3 and are therefore unable to upregulate 
glycolytic production of ATP in an activated state (Yang et al. 2016). In consequence, cells 
are forced to increase the shuffle of acquired glucose to the pentose phosphate pathway, 
which results in the production of increased levels f NAPDH. NAPDH reduces glutathione 
which is a mayor ROS scavenger. Lower levels of ROS affect intracellular signaling 
pathways in cells resulting in insufficient activation of the redox-sensitive kinase ataxia 
telangiectasia mutated (ATM), which leads to a bypass of he G2/M cell cycle checkpoint 
leading up to a hyper-proliferation and differentiation towards Th1/Th17 phenotype. The 
study aiming at the chronically stimulated human memory T cells isolated ex vivo from 
autoimmune disease systemic lupus erythematosus (SLE) patients has shown that cells 
secure ATP production through oxidative phosphorylation while glycolytic activity is 
significantly lower than in acutely activated cells or lymphocy es from healthy patients (Wahl 
et al. 2010). 
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1.3.3 Synovial hypoxia 
Thickening of the synovial lining, large numbers of infiltrating T cells, B cells and 
macrophages, vascular damage and swelling cause interruption of blood supply leading to 
lower oxygen tensions that are typical in the inflammatory and invasive rheumatoid arthritis 
(RA). Oxygen tensions range between approximately 2 % - 4.4 % oxygen (18 to 33 mmHg) 
in inflamed synovium compared with 8.5% to 13.5% (65 to 103 mmHg) in healthy individuals 
blood (Lewis et al. 1999; Sivakumar et al. 2008). A major transcriptional regulator of low 
oxygen tension is HIF1-α. HIF1-α belongs to the bHLH protein family and functionally needs 
to form a heterodimer with a β-subunit. The α-subunit undergoes oxygen-dependent 
hydroxylation by PHD, resulting in ubiquitination and degradation by the proteasome. 
Besides O2- dependent hypoxic stabilization of the HIF1-α subunit, other stabilizers of HIF1-α 
exist in normoxic cells such as TNF-α. TNF-α has been shown to increase the accumulation 
and transcriptional activity of HIF1-α in a NF-κB dependent manner, without affecting its 
mRNA (Jung et al. 2003).  
 
1.3.4 Reactive oxygen species in synovial CD4+ T cells  
The cell possesses a natural ability to scavenge O2-, H2O 2 molecules through three main 
antioxidant enzymes - superoxide dismutase (SOD), catalases (CAT) and glutathione 
peroxidases (GPX). Nevertheless, if ROS are overproduced and not scavenged, widespread 
lipid, protein, mitochondrial and DNA damage occurs (Filippin et al. 2008). Moreover, ROS 
have a high affinity to lipids. Lipid peroxidation was foun to be ncreased in a synoviocytes 
of RA patients, while the antioxidant status of the cells accessed by levels of GSH and SOD 
was impaired (Seven et al. 2008). Lipid peroxidation is a major cause of an alternative form 
of iron-dependent, regulated non-apoptotic cell death, Ferroptosis and is mainly inhibited by 
the repair enzyme glutathione peroxidase 4 (GPX4) (Yang and Stockwell 2016). GPX4 has 
been shown to be crucial for Th1 mediated anti-parasitic responses in both normoxia, and 
hypoxia (Matsushita et al. 2015). So far, levels of GPX4 were not assessed in patients with 
RA. However glutathione serum levels were reported to be decreased by 50% in patients 
with RA, compared to healthy serum donors (Hassan et al. 2001).  
1.3.5  Proteomic and metabolome analysis of synovial fluid  
 
Synovial fluid (SF) provides both lubrication and nutrition to the joint. Nevertheless, the 
majority of SF from rheumatologic patients contains IFN-γ (median level 17 pg/ml) in addition 
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to monokines such as IL-6 (4700 pg/ml) and TNF-α (157 pg/ml) (Steiner et al. 1999). 
Moreover, rheumatoid synovium is associated with an increased production of adipokines, 
such as leptin and adiponectin that were identified as relevant factors involved in interactions 
between metabolism and rheumatic disorders (Conde et al. 2011). In a mass spectrometry 
proteomic comparative study of proteins upregulated in synovial fluid of a RA joint in 
comparison to protein expressed in synovial fluid of osteoarthritic patients (Balakrishnan et 
al. 2014), it was found that an oxidoreductase myeloperoxidase that is associated with 
oxidative stress in the inflamed joints (Stamp et al. 2012; Balakrishnan et al. 2014) was 16x 
upregulated in RA synovium in contrast to osteoarthritis. Coro1a, a phagosome protein with a 
role of in a T cell survival (Mueller et al. 2008) is 6 times higher. Additionally several enzymes 
involved in the glycolytic pathway were upregulated in synovial fluid of rheumatic patients 
such as glyceraldehyde 3-phosphate dehydrogenase, lactate dehydrogenase (Henderson et 
al. 1979), hexokinase (HK3) (Logvinenko Iu et al. 1982; Zborovskaia 1983) glucose 
phosphate isomerase (GPI) (Schaller et al. 2006), enolase 1 (ENO1) and ALDOA 
(Balakrishnan et al. 2014). Nevertheless, the cellular source of these enzymes has not been 
identified and it is probable that glycolysis is highly upregulated in cells that produce large 
amounts of antibodies, such as plasma cells (Neuman 2015). An abundance of succinate, 
aspartate, glutamate, and citrulline in synovial fluid from patients with RA attests to 
involvement of the TCA cycle (Kim et al. 2014).  A 2016 study highlighted increased levels of 
fatty acids and cholesterol and decreased levels of amino acids and glucose in patients with 
RA (Zhou et al. 2016).  
1.4 Twist 1 – the hallmark of repeatedly activated Th1 cells  
In various animal models, Th1 cells with a history of repeated activation by (auto-) antigen 
accumulate in inflamed tissues (Fuss et al. 1996; Morita et al. 1998; Yamada et al. 2008). 
Similarly, effector memory Th1 cells persisting in the microenvironment of the inflamed tissue 
(Niesner et al. 2008) were found in patients suffering from chronic inflammatory joint or gut 
diseases. These cells express high levels of Twist1, a bHLH transcription factor hallmarking 
repeated stimulation in vitro and i  vivo (Niesner et al. 2008). In vitro, Twist1 is gradually 
upregulated in murine Th1 cells with every round of re-stimulation and its transcription 
depends on IL-12/STAT4 signaling and NF-κB and NFAT mediated activation. It is 
considered as a Th1 specific transcription factor. Indeed, relatively to Th1, it is minimally 
expressed in Th2 or Th17 after repeated activation (Niesner et al. 2008). Twist1 represents 
an endogenous regulator of pro-inflammatory Th1 cells and is recognized as a suitable 
biomarker for the pathogenic memory Th1 compartment generated during chronic 
inflammation (Niesner et al. 2008). Knockdown of Twist1 in Th1 cells used in an adoptive 
Introduction 
 
26 
 
transfer model of antigen-induced arthritis results in severe inflammation and tissue 
destruction by cellular infiltrate, the two major characteristics of chronic inflammation.  
 
1.4.1  Molecular properties and function of Twist1  
Twist1 is a transcriptional repressor and a member of the basic helix-loop-helix (bHLH) family 
(Barnes and Firulli 2009). The transcriptional regulatory outcomes of Twist1 are dictated by 
several factors that include its spatial and temporal cellular expression, protein–protein 
interactions with other bHLH proteins (Castanon et al. 2001), post-transcriptional regulation 
by phosphorylation and accessibility of the other E-box proteins (Firulli and Conway 2008). 
Twist1 has the generic basic- helix- loop- helix (bHLH) modular structure. At the C-terminal 
region is located the Twist box (WR) (Kadesch 1993) important for its dimerization. GSK3 
mediated phosphorylation of WR domain is crucial for dimerization with non-bHLH 
transcription factors (Lander et al. 2013). The N-terminus region interacts with the E-box 
sequence (CANNTG) on target genes and is responsible for DNA binding (Massari and 
Murre 2000). The momentary balance among Twist1, Id, and E proteins is likely important in 
defining Twist1 activity (Hayashi et al. 2007) throughout binding to is co-factors (Connerney 
et al. 2006). The level of Twist1 phosphorylation further dictates the transcriptional outcome. 
PKA, PKC, PKB/Akt, and PP2 can all determine phosphorylation levels of Twist1 at highly 
conserved Ser and Thr residues in the HLH region (Firulli and Conway 2008). Complexity of 
potential Twist1 mediated mechanisms contributes to diffi ul  prediction of transcriptional 
outcome. Twist1 was first shown to play a positive role in dorsoventral patterning in 
Drosophila embryos (Barnes and Firulli 2009), cancer survival and metastasis (Yang et al. 
2008; Kawagoe et al. 2007). In neuroblastoma, Twist1 acts as negative feedback inhibitor of 
Myc induced apoptosis (Kawagoe et al. 2007). In immune cells, Twist proteins are key 
regulators of NF-κB– mediated inflammation, as Twist2 deficiency, or haploinsufficiency of 
Twist1 and Twist2, results in a lethal systemic flammatory me abolic syndrome linked to 
enhanced proinflammatory cytokine production (Sosic et al. 2003; Sharif et al. 2006). In Th1 
cells Twist1 limits inflammation by suppressing IL2, IFN- a d TNF-a product on (Niesner et 
al. 2008) by interaction with RunX3, binding partner of T-bet for the activation of the IFN-γ 
promoter (Pham et al. 2012). Role of Twist1 in metabolism has been described in adipose 
tissue and muscle cells (Pan et al. 2009; Mudry et al. 2015b; Pettersson et al. 2010). In white 
adipose tissue, characterized by low grade, long lasting inflammation, Twist1 silencing 
reduces FAO together with modulation of IL6 expression via reduction of CPT1 (Pettersson 
et al. 2010). In brown adipocytes Twist1 is a negative feedback regulator of PPAR-δ/PGC1 α 
inhibiting energy expenditure in mitochondria (Pan et al. 2009). Interestingly, Twist1 has 
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been also shown to inhibit c-Myc-induced ROS accumulation and apoptosis in 
carcinogenesis (Floc'h et al. 2013). 
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 Results 
 
2.1 Chronically activated T cells decrease glucose uptake and 
glycolysis 
In order to study metabolic adaptation to a repeated Th1 cell activation, we employed the 
established in vitro model of Th1 mediated chronic inflammation, described in Methods 
section 3.2.2 and in Figure 2-1. 
 
 
Figure 2-1: In vitro chronic inflammation model to study metabolic adaptation: 
Schematic representation and experimental set up of an in vitro model mimicki g effector (once 
restimulated) and repeatedly restimulated (three times stimula ed) differentiation of CD4+ Th1 cells. 
Right part depicts experimental set-up of metabolic profiling. Glucose uptake was monitored by flow 
cytometry analysis of fluorescent analogue of glucose (2-NBDG) uptake; glycolysis and oxidative 
phosphorylation (OXPHOS) was assessed by monitoring of its surr gate markers- acidification rate 
(ECAR) and oxidative consumption rate (OCR), respectively. 
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For a long-term Th1 culture, CD4+ CD62L+ cells, defined as naïve, were isolated from CD4-
Cre-Twist1wt/wt and CD4-Cre-Twist1loxP/loxP mice. Cells were re-stimulated in 6-day intervals:  
once - to achieve effector Th1 cell phenotype, or three times - to achieve chronically 
stimulated, or “pathogenic memory” Th1 cell phenotype. Three times restimulated Th1 
lymphocytes might reflect cells that can be found in patients with a chronic autoimmune 
disease. To study metabolic properties of above-mentioned Th1 phenotypes, viable cells 
were isolated after 6th day or 18th day of the culture using Ficoll density gradient and their 
metabolic properties were analyzed. First, to monitor glucose uptake during activation, both 
phenotypes were re-stimulated for 6 hours with CD3/CD28. Prior to the addition of the 
fluorescent glucose analogue 2-NBDG, cells were starved of glucose for another 60 min in 
the glucose-free media. After the addition of fluorescent analogue 2-NBDG, glucose uptake 
was analyzed by a flow cytometer in FL1 channel. The uptake of glucose was reduced by 
2.3-fold in three-times activated Th1 cells compared to Th1 cells which were reactivated 
once (Figure 2-2, black bars). Controls were done by blocking glucose uptake with 
Cytochalasin B (gray bars), that blocks entrance of glucose to the cell. They showed that 
once activated Th1 cells took up 3.5-fold more 2-NBDG than control cells in contrast to 
repeatedly stimulated Th1 cells that took up in average only 2-fold more 2-NBDG than 
control cells (Figure 2-2). 
 
 
 
 
 
 
 
 
 
 
Figure 2-2: Repeatedly stimulated Th1 cells decrease their glucose uptake. :  
Glucose uptake is depicted as the mean fluorescence intensity (MFI) of intracellular 2-NBDG 
molecules of in vitro cultured 6 (once re-stimulated) or 18 (three times re-stimulated) days old TH 1 
polarized cells. Prior to uptake, cells were restimulated 6h with 3μg/ml of CD3 and 1,5 μg/ml of 
CD28. Fluorescence was analyzed by FACS after 6h of CD3/CD28 stimulation and subsequent 
exclusion of PI+ dead cells. Cells treated with Cytochalasin B, glucose transport blocker, were used 
as an internal background control. Data is presented as mean, with SEM, representative of three 
independent experiments. Statistics: Mann Whitney test, two tailed  
 
Results 
 
30 
 
Next, in order to analyse the activity of two major cellular energetic pathways - glycolysis and 
oxidative phosphorylation, we used Seahorse XF96 analyzer that measures a rate of lactate 
output and oxidative consumption, its respective ind cators. Prior o the measurement, cells 
were washed several times in glucose-free media and seeded in a glucose-free medium for 
minimum 1 hour. First, we compared metabolic parameters of cells th t have no access to 
glucose, as resting, non- stimulated cells. In comparison to resting/glucose deprived once 
stimulated Th1 cells, resting/glucose deprived repeatedly stimulated Th1 cells had minor, 
nevertheless significant increase in lactate production (Figure 2-3a) and highly increased (2-
fold) oxidative consumption rate (Figure 2-3b). After the addition of glucose (Figure 2-3c), we 
monitored percentage of baseline (baseline= glucose-starved ce ls ECAR) acidification rates. 
Upon addition of glucose, once activated Th1 cells upregulated their glycolysis 1.4-fold more 
compared to repeatedly activated Th1 cells (Figure 2-3c), 0 min. The increased lactate 
production of once activated Th1 cells was maintained following re-activation with PMA/ 
Ionomycin (marked with an arrow, 28 min). Although OCR dropped following provision of 
glucose and re-stimulation with PMA/Ionomycin (arrow PMA/Iono), repeatedly activated Th1 
cells maintained higher OCR compared to once activated Th1 cells (Figure 2-3d).  
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Effector T cells were previously shown to depend on glycolysis for activation-induced 
proliferation, survival and effector function (Michalek et al. 2011; Yaqoob and Calder 1997; 
Chang et al. 2013). To investigate the level of dependency on glycolysis in once and three-
time (repeatedly) stimulated Th1 cells we compared their post-activation survival in the 
presence of glycolysis inhibitor 2-Deoxy-D-glucose (2DG) (Pelicano et al. 2006). 2- DG is a 
glucose analogue that is phosphorylated on the 6th osition to form 2-DG6P and cannot be 
Figure 2-3 After glucose addition, three times stimulated Th1 cells decrease glycolysis and 
increase oxidative phosphorylation in contrast to once stimulated Th1 cells: 
(a) mean value of acidification rate and (b) xid ive consumption rate of in vitro cultured, resting, 
glucose deprived Th1 cells cultured for 6 (once re-stimulated) or 18 (three times re-stimulated) days 
(c) mean % of extracellular acidification rate (ECAR) derived from supplied glucose before and after 
stimulation with PMA/Ionomycin (indicated with an arrow) ( ) oxygen consumption rate in cells 
before addition of glucose, after addition of glucose  (arrow - glucose) and after stimulation with 
PMA and Ionomycin (arrow- PMA/Iono). Paired T test P < 0.0001 as of 60min after PMA/IONO 
activation in c,d. Graphs are representative of thee independen  experiments. Error bars indicate 
SEM.  
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metabolized further by glycolytic enzymes and therefor  inhibits glycolysis (Pelicano et al. 
2006). A culture of cells with selective glycolysis inhibitor 2DG resulted in 85% decrease in 
recovery of cell numbers 72 hours after re-activation of once activated Th1 cells compared to 
a 50% reduction in recovery of repeatedly stimulated Th1 cells (Figure 2-4a). We 
hypothesized that reduction in glycolysis indicates a shift towards oxidation of fatty acids, as 
memory CD8 T cells were shown to be dependent on oxidation of fatty acids (Pearce et al. 
2009) synthesized intracellularly (Weinberg and Chandel 2014). Nevertheless, dependence 
on FAO was never shown in memory T cells, or the repeatedly activated CD4+ T cells. To 
this end, we cultured repeatedly stimulated Th1 cells in a presence of Etomoxir, an inhibitor 
of carnitine palmitoyltransferase-1 (CPT1) (Horn et al. 2004), the rate-limiting enzyme of fatty 
acid oxidation. Repeatedly activated Th1 cells did not survive in culture conditions where 
fatty acid oxidation was inhibited by Etomoxir (Figure 2-4b). 
 
 
A legend on page 33 
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On day 2 and day 3 after anti-CD3/ anti-CD28 stimulation cell numbers were higher in 
Etomoxir treated repeatedly stimulated Th1 cells, nevertheless did not survive 5 days 
post stimulation (Figure 2-4b). Analysis of glycolytic rate using Seahorse showed that 
Etomoxir treatment increases glucose - derived glycolytic rates in repeatedly stimulated 
T cell (Figure 2-4c). PD-1, marker of follicular T helper cells has been previously linked 
to an increase of oxidation of fatty acids and a decrease of glycolysis in T cells 
(Patsoukis et al. 2015) and it is also a marker of pathogenic synovial T cell population 
found in the joint of RA patients (Rao et al. 2017a). We observed upregulated mRNA 
expression of PD-1 in i vitro three-time stimulated murine Th1 cells, compared to once 
stimulated murine Th1 cells (Figure 2-5). 
 
 
  
 
Figure 2-4: Repeatedly stimulated Th1 cells are less dependent on glucose for post-
activation survival and need oxidation of fatty acids for a long term survival:  
(a) Mean frequency with SEM of viable (DAPI-) CD4+ T cells stimulated once (white bar) or 
repeatedly (black) following restimulation with α-CD3/α-CD28 antibodies in the presence of the 
glycolysis inhibitor 2-DG (2 mM) for 72h relative to cells cultivated without inhibitor as determined 
by flow cytometry. **p=0.01, Mann Whitney two tailed test, xperiment was repeated 3 times (b) 
absolute mean cell number (error bar = SEM) of in vitro CD3/CD28 repeatedly stimulated  Th1 
cells  in control full nutrient medium (black line) o  medium supp emented with 150 µM Etomoxir 
(red line). Surviving cells were counted by CD4+/PI-gating strategy in FACS (c) % of extracellular 
acidification rate derived from added glucose in presence of 150 μM Etomoxi  before and after 
stimulation with PMA/Ionomycin (indicated with an arrow). Experiment was repeated 3 times. 
Figure 2-5 Three times stimulated Th1 
cells upregulate pd-1 mRNA 
expression: 
Prior to the RNA isolation and 
measurement of real-time expression of 
pd-1, once and repeatedly (three times) 
stimulated Th1 cells were cultured in 
vitro for 6 and 18 days, respectively, and 
re-stimulated by PMA/ Ionomycin for 6 
hours. Mean with SEm is indicatedTwo 
tailed t-test, 0.0083. n=2 
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2.2 Phenotypical analysis ofex vivo i olated Juvenile idiopathic 
Arthritis CD4+ T cells  
In vitro murine culture studies suggested survival dependency of repeatedly stimulated Th1 
cells on fatty acid oxidation. Therefore, we aimed to relate findings of in vitro culture model to 
metabolic phenotype of ex vivo autoimmune CD14- CD4+ T cells that were isolated from a 
synovial fluid of patients with rheumatoid disease represented by Juvenile idiopathic Arthritis 
(JIA). First, to exclude macrophages and monocytes that express CD4 surface marker, 
CD14+ cells were isolated out of cellular suspension by Magnetic Activated Cell Sorting 
(MACS). Subsequently, CD4+ cells were isolated and analysed by flow cytometry for 
memory markers, cytokine and transcription factor expression. The phenotypic 
characterization of CD4+ T cells has shown that 92% of CD4 T cells from synovial fluid were 
memory cells (Figure 2-6). On contrary, blood cells were shown to contain about 52% of 
CD45 RO+ cells and 38% of CD45 RO- CD45 RA+ CD4 T cells. In further experiments we 
will consider cells isolated from JIA patients as prevalently CD45RO+ positive.  
 
 
Figure 2-6 Ex vivo isolated CD4+ CD14- T cells from joints of JIA patients are memory CD4+ T 
cells: 
Flow cytometric analysis indicating frequencies of CD45RA+ naive  and CD45RO+ memory phenotype 
cells among CD3+CD4+ T cells in blood and synovial fluid of JIA patients  
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In order to further characterize cells by cytokine expression, cells were re-stimulated for 5-7 
hours in complete human RPMI medium with PMA/ Ionomycin and BrefeldinA, fixed, stained 
for lineage-specific cytokines and analyzed by flow cytometry. Upon PMA/Ionomycin re-
stimulation, in average 52% of cells expressed IFN-γ and approximately 70% of CD4 T cells 
expressed TNF-α, Th1- associated cytokines (Figure 2-7). Only minimum of cells expressed 
IL17 (Figure 2-7a,b). We found a low number of IL-4 and IL-21 expressing cells while IL-10 
was expressed on average by 8% of cells, and these ce ls were also producers of IFN- γ 
(Figure 2-7b). Majority of T cells isolated from synov al fluid also expressed T-bet in contrast 
to effector and memory T cells isolated from patients’ blood (Figure 2-7c). 
 
Figure 2-7: ex vivo isolated CD4+ CD14- T cells from joints of JIA patients secrete upon re-
stimulation Th1- specific cytokines and lineage specific transcription factor T-bet:  
(A) Expression of IFN-γ, TNF-α, IL-2, IL-10, IL-4, IL-21 and IL-17A in ex vivo isolated synovial T cells 
as analyzed by intracellular cytokine staining following restimulation with PMA/Ionomycin for 5-7 
hours. A representative plot of n=5 is shown. (B) Frequencies of synovial fluid CD4+ T cells 
expressing IFN-γ, T F α, IL-2, IL-10, IL-4, IL-21 and IL-17A.  Data shown are mean+/-SEM of 5 
patients. (C) Flow cytometric analysis of T-bet expression in CD4+CD45RO- T cells from blood and 
CD4+CD45RO- and CD4+CD45RO+ T cells from synovial fluid of a JIA patient. A representative 
staining of n=3 is shown. 
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PD1+ CD4+ T cells were shown to be expressed in the synovial fluid of rheumatoid arthritis 
patients (Li et al. 2014). Recently it was suggested that peripheral CD4+ T cell population of 
cells expressing PD1 play a pathogenic role in syn vial inflammation (Rao et al. 2017a). To 
address expression of PD1 in memory CD4+ T cells isolated from synovial fluid of JIA 
patients, we measured PD1 expression in CD4+CD45 RO+ cells acquired from their synovial 
fluid and blood. Upfront, CD15+, dead and CD14+ cells and gated out using flow cytometry.  
 
 
Figure 2-8: ex vivo isolated memory CD4+ T cells from synovial fluid of JIA patients express 
PD1+ in contrast to the memory CD4+ T cells isolated from the blood: 
Mean fluorescence intensity (MFI) of PD1 staining in C 4- CD15 - alive effector (CD4+CD45 RO-) 
and memory (CD4+CD45 RO+) T cells isolated from bl od and synovial fluid that were re-stimulated 
with PMA and Ionomycin. PD-1 staining of non-stimulated CD14- CD15 - CD4+CD45 RO+ and 
CD4+CD45 RO- cells is also shown (synovial non-stimulated). Staining was repeated three times. 
 
 
To investigate the influence of individual metabolic pathways on survival of stimulated or 
non-stimulated CD14-CD4+ T cells isolated ex vivo from patients with Juvenile idiopathic 
arthritis, we employed selective inhibitors of glycolysis - 2DG, glutaminolysis - DON (Willis 
and Seegmiller 1977), fatty acid oxidation - Etomoxir   and OXPHOS – Oligomycin (Bertina et 
al. 1974) and compared CD4+ synovial cells to a CD4+cells isolated from blood of these 
patients (Figure 2-9). 
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Figure 2-9: Selective sensitivity of JIA rheumatoid synovial CD4+ T cells to inihibitors of 
oxidative metabolism:  
CD4+ CD14- T cells were isolated from joints of rheumatic patients using magnetic sorting and 
cultivated with human serum in 4 % oxygen with addition of inhibitors of glycolysis (2DG) fatty acid 
oxidation (Etomoxir) or OXPHOS (Oligomycin) in presence or absence of anti-CD3/anti-CD28 (a) 
mean total cell count (with SEM) with of alive (DAPI- CD4+ number of cells iso ated from synovium 
and blood, stimulated with anti-CD3/ anti-CD28 or synovial cells not stimulated over course of 8 days  
(b) mean % (with SEM) of surviving  of stimulated, unstimulated synovial and blood derived CD4+ 
cells on day 2 and day 8 after initiation ex vivo culture. n= 2. Differences were not significant. 
 
Upon stimulation with anti-CD3/ anti- CD28, synovial CD4+ T cells treated with all metabolic 
inhibitors were able to survive until day 8 (Figure 2-9a), further time points were not 
assessed. Surprisingly, if cells were not stimulated, cells were unable to survive after day 4 
(Figure 2-9a – no stimulus, synovium). Cells isolated from blood timulated with anti - CD3/ 
anti-CD28 were not able to survive more than 4 days in the culture (Figure 2-9a), irrespective 
of the metabolic inhibition (Figure 2-9a- CD3/CD28, blood). Two days after ex vivo isolation 
both anti-CD3/ anti-CD28 stimulated and un-stimulated synovial CD4+ CD14- T cells treated 
with glycolysis inhibitor 2DG had on average 20% lower survival than control cells (Figure 
2-9b). Cells treated with inhibitor of oxidatve phosphorylation, Oligomycin, presented on 
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average 12% less surviving cells than control on day 2. On day 8, non-stimulated and blood 
derived CD4 memory cells did not survive, while 60% of synovial CD4 T cells cultured in 
control medium survived up until day 8, compared to 40% of cells treated with inhibited 
OXPHOS or FAO and compared to 78% of cells treated with glycolysis inhibitor 2DG (Figure 
2-9b).  
2.3 Engagement of TCR is not crucial for homeostatic 
proliferation of ex v vo is lated CD4 T cells 
Next, we investigated proliferation of CD4+ T cells isolated ex vivo from patients with 
Juvenile Idiopathic Arthritis in control medium and in medium containing metabolic inhibitors. 
Cells were stained with proliferation dye and measured in 2 day intervals with flow cytometry. 
Proliferation was comparable between stimulated (stim.) and unstimulated (ns.) CD4+ T cells 
(Figure 2-10a). As assessed by measurement of prolif ration of surviving cells on day 8, cells 
proliferated minimally (Figure 2-10 ). Metabolic inhibition of OXPHOS by Oligomycin, FAO by 
Etomoxir or glycolysis by 2DG had comparable effect on proliferation that was slightly 
hampered in comparison to control conditions (Figure 2-10b).   
 
Figure 2-10 Proliferation of ex vivo cultured anti-CD3/anti-CD28 stimulated and not stimulated 
CD4+ CD14- cells isolated from JIA patients:  
(a) Cells cultured in control medium assessed by staining with Cell Proliferation Dye eFluor 670 by 
flow cytometry (b) proliferation of cells cultured in media c ntaining metabolic inhibitors of glycolysis 
(2mM 2DG) fatty acid oxidation (150 μM E omoxir) or OXPHOS (2 μM Oligomycin). 
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2.4 Pathogenic memory PD1 + CXCR5- synovial CD4+ T cells 
is selectively sensitive to inhibition of fatty acid oxidation 
Studies suggest that the expanded CD4+ PD1 + CXCR5- population activates antibody 
production in B cells at the inflamed joint and therefore supports ongoing autoimmune 
inflammation (Rao et al. 2017a).  
 
Figure 2-11 Memory CD4+ CD45RO+ PD1+ T cells isolated from inflamed tissue of JIA patients 
do not survive in FAO limiting condition. 
(a) CD4+ CD14- CD45RO+T cells were sorted according to a PD1 and CXCR5 expression, seeded in 
density of 70 000 cells and stimulated by CD3/CD8 RPMI+10% human serum+ 200 μM Etomoxir 
(FAO blocker)(b) % survival of initially seeded cells was assessed on day 2 and day 4 after anti-
CD3/anti-CD28 stimulation. Cells were cultured under 4 % oxygen. Statistics: two- tailed T test, P 
value= 0.0002 (***) 
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PD-1 inhibits PI3K mediated downregulation of CPT1, resulting in preference to oxidize fatty 
acids as an energy source over glycolysis (Patsoukis et al. 2015). Selective dependence of 
pathogenic memory CD4+ T cells present in rheumatic synovium on fatty acid oxidation have 
not been shown so far. We isolated CD14- CD4+ T cells from blood and synovial fluid of 
Juvenile Idiopathic Arthritis patients by magnetic or ng and used flow cytometry to sort 
CD15 - CD45RO+ CXCR5- PD1+ and CD15- CD4+ CD45RO+ CXCR5- PD1- populations of 
T cells. Subsequently, we investigated whether this pathogenic PD1 expressing population of 
synovial CD4+ T cells within the synovial memory T cells population can be selectively 
starved by inhibition of fatty acid oxidation in vitro. Sorted populations were cultured ex vivo 
in medium with or without fatty acid oxidation inhibitor Etomoxir. Blood CD4+  CD45RO+ T 
cells did not survive culture in vitro under control or fatty acid oxidation inhibitory conditions, 
and PD1- cells had comparable low survival rate in both cont ol and fatty acid oxidation 
limiting conditions on day 4, PD1+ memory CD4+ T cells cultured in control medium had 
significant survival advantage over PD1– memory T cells. This survival advantage could be 
abrogated by inhibition of fatty acid oxidation, as on day 4 cells treated with Etomoxir had 
lover survival rate than cells not expressing PD1, treated with Etomoxir (Figure 2-11b).  
2.5 CD4+ CD45RO + PD1+ CXCR5- pathogenic memory T 
cells upregulate transcription factor Twist1 that medi tes 
downregulation of glycolytic and oxidative pathways  
 
Next, we were interested in further characterization of pathogenic PD1+ CXCR5 – CD4+ T 
cell population. To this end we measured mRNA of hallmark transcription factor of 
autoimmune cells in rheumatoid arthritis, Twist1. Cells were sorted by flow cytometry, left 
unstimulated, re-suspended in a RNA lysis buffer and RNA was isolated. Twist1 expression 
was assessed by real time PCR. CD4+ CD45RO + PD1+ CXCR5- pathogenic memory T 
cells had increased transcriptional levels of Twis 1 (Figure 2-12) in contrast to CD4+ 
CD45RO + PD1- CXCR5- or blood counterparts. 
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Figure 2-12 mRNA of Twist1 is upregulated in PD1+ subset of CD4 + CD45 RO+ cells isolated 
from synovia of Juvenile Idiopathic Arthritis patients:  
Twist1 mRNA expression in ex vivo isolated PD-1+ and PD-1- CD4+CD45 RO+ cells isolated from 
synovial fluid (SF) or blood of JIA patients. Cells were sor ed by FACS. mRNA levels are shown 
relative to HPRT. n=2 mean with SEM. Significance was not determined due to a limited amount of 
sample. 
 
Twist1 has been implicated in regulating the survival of Th1 cells (Niesner et al. 2008; 
Haftmann et al. 2015), however its function in energy homeostasis and fatty acid metabolism 
is only known in adipocytes (Pan et al. 2009; Pettersson et al. 2010) and muscle cells (Mudry 
et al. 2015b). To investigate impact of Twist1 on metabolism of once and repeatedly 
activated Th1 cells, we measured lactate production and oxidative consumption in WT and 
Twist1-deficient cells of both phenotypes. Recombinant mouse used harbours Cre 
recombinase, driven by CD4 promoter. Cre recombinase recognizes two LoxP sites that are 
flanking Twist1 allele and therefore Twist1 is only deleted in CD4 T cells.  
Twist1 deficiency resulted in an increased ECAR both in once (Figure 2-13a) and in three-
times activated (Figure 2-13b) Th1 cells. Increased glycolysis was observed after addition of 
glucose also in three times stimulated Twist1 deficient Th17 cells, nevertheless the 
difference in glycolysis between wild type and Twist1 fl/fl deficient repeatedly activated Th17 
was not after re-activation with PMA/Ionomycin (Figure 2-13c). Surprisingly, OXPHOS was 
downregulated by Twist1 during activation with PMA/Ionomycin in three time stimulated Th1 
cells (Figure 2-13e) in a higher level than in once (Figure 2-13d) stimulated Th1 cells. Twist1 
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deficiency did not influence oxidative consumption of hree time stimulated Th17 cells (Figure 
2-13f). Legend to the  Figure 2-13 on the next page. 
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Figure 2-13 Twist1 inhibits metabolism upon activation in once and repeatedly stimulated Th1 
cells: 
(a,b,c) Extracellular acidification rate as indica or of glycolysis (ECAR) and (d,e,f) oxidative 
consumption rate (OCR) as an indicator of oxidative phosphorylat on of Twist fl/fl CD4 Cre Th1 cells 
(circle)  and Twist wt/wt  CD4 Cre cells (square) stimulated with OVA peptide in vitro for (a,d) 6 days 
(once stimulated Th1 cells) or (b,e)  18 days (three time stimula ed ) and (c,f) three time stimulated 
Th17 cells. Significance for a) p= 0,0006 at 28 min; p= .0001 at 52 min, b) p=0.0001 at 28 min; 
p=0.0013 at 52 min c) p=0.0135 at 28 min; p=ns at 52 min d) p=0.0027 at 28 min; p=0.0111 at 52 min 
e) p=0.0002 at 28 min; p=0.051 at 52 min  f) p=0,36 (ns) at 28 min; p=0.47 (ns) at 52 min, all paired t 
test. Graphs are representative of three independent experiments. 
2.6 Global Affymetrix transcriptome of repeatedly stimulated 
Th1 Twist1 fl/fl cells  
To understand Twist1-mediated regulation of metabolic genes in chronically stimulated T 
cells, we performed comparative Affymetrix anal sis of repeatedly stimulated Twist1- 
deficient cells. Twist1 was deleted by recombinant protein TAT-Cre 3 days before last re-
activation for RNA collection and compared to repeatedly stimulated, TAT-Cre treated WT 
Th1 cells (Figure 3-1). In total, we observed differential regulation of 73 genes (Figure 
2-15a). No Th1 cytokine coding genes showed up in the microarray analysis of repeatedly 
stimulated Th1 cells. This was surprising, as Twi t1 has been shown to downregulate Th1 
cytokine expression in vitro: upon Twist1 overexpression in once stimulated Th1 cells, 
expression of IFN-γ, TNF-α and IL2 was decreased (Niesner et al. 2008). To validate this 
result, we analysed Th1 cytokine expression by flow cytometry in repeatedly stimulated Th1 
cells. Twist1 WT  once stimulated Th1 cells expressed in average 36% TNF-α /63% IFN-γ 
(Figure 2-14).  In comparison to  Twist1 deficient once stimulated Th1 expressed in average 
55% TNF-α /83% IFN-γ, confirming previous findings of Twist1 mediated cytokine 
suppression. Twist1 WT in vitro repeatedly stimulated Th1 cells expressed in average 83% 
TNF- α /92% IFN-γ in comparison to Twist1 deficient repeatedly stimulated Th1 expressed in 
average 85% TNF-α /90% IFN-γ. Over all, in in vitro Th1 culture, Twist1 downregulate IFN-γ 
and TNF-α in once, but not in repeatedly stimulated Th1 cells.   
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Figure 2-14 Twist1 downregulates IFN-γ, TNF-α in once, not repeatedly stimulated Th1 cells: 
Twist1+/+ and Twist1 fl/fl CD4 Cre OTII TH 1 cells were stimulated under TH 1-polarizing conditions 
(T H 1) with ova327-339 and APCs for 6 days or 24 days. On d 6 survivi g cells were isolated with Ficoll 
and restimulated with PMA/ ionomycin in the presence of brefeldin A for 5 h and stained for 
intracellular cytokine expression. Representative dot plots of cytokine expression in TH  cells are 
displayed. The single live cells were gated (b) frequencies of TNFα and (c) IFNγ cytokine expression. 
Data represent the mean ± s.d. of 5 independent measurements. 
 
 
Interestingly, highest number of genes was involved in regulation of apoptosis and 
metabolism. Differentially regulated genes and their function in metabolism are shortly 
described here:  Ppp1r3b codes for regulatory unit of protein phosphatase 1 (PP1), acting as 
Results 
 
45 
 
an activator (dephosphorylator) of glycogen synthase kinase (GSK3) and another enzymes 
involved in glycogen synthesis, glucose and triglyceride metabolism (Ceulemans and Bollen 
2004; Zhang et al. 2014). In CD8 T cells, GSK3 inhibits T-bet function and upregulates PD1 
expression (Taylor et al. 2016). Moreover, interactions between Twist1 and its transcriptional 
co-factors are controlled by GSK3 mediated phosphorylation (Lander et al. 2013). Activating 
transcription factor 5 (ATF5) protein product promotes mitochondrial function and recovery 
from mitochondrial stress (Fiorese et al. 2016) and regulates lipid metabolism in adipocytes 
(Jiang et al. 2016). Glut3 andGlut1 are coding for proteins mediating a glucose uptake in T 
cells (Gerriets et al. 2015). Oxct1 codes for an enzyme catalyzing formation of Acetoacetyl-
CoA, critical metabolite for formation of cholesterol, lipid and short-chain acyl-CoAs 
(MacDonald et al. 2009). PAICS (ADE2) codes for Phospho - ribosylaminoimidazole- succino 
- carboxamide synthase involved in production of purines in a pentose phosphate pathway. 
Gpx4 codes for a NAPDH dependent peroxidase, catalysing scavenging of lipid peroxides by 
oxidation of reduced glutathione. Upon inhibiion of GPX4, cells undergo newly identified 
non-apoptotic iron dependent cell death called Ferroptosis (Yang et al. 2014; Yang and 
Stockwell 2016). Rdh 1 codes for a NADPH-dependent retinal reductase, playing a role in 
regulation of oxidative stress, and is also involved in the met bolism of lipid peroxide derived 
- short-chain aldehydes (Kasus-Jacobi et al. 2003). Gpt2 codes for a mitochondrial alanine 
transaminase that catalyzes the reversible transamination between alanine and 2-
oxoglutarate to generate pyruvate and glutamate during glutaminolysis, therefore being 
essential in TCA anaplerosis, crucial feature for synthesis of fatty acids (Ouyang et al. 2016).  
Furthermore, we observed a differential expression of Bnip3. Bnip3 plays a role in 
autophagy-mediated survival of memory cells (Gang et al. 2015; O'Sullivan et al. 2015). 
Effector lymphocytes expressing Bnip3 elude cell death and do persist and form memory by 
utilizing lysosomal autophagy of accumulated mitochondria and ROS scavenging via 
activated AMPK- Atg3/Bnip3 pathway (O'Sullivan et al. 2015). Further, in liver, Bnip3 
supports oxidation of fatty acids and in maintaining the mitochondri l integrity (Glick et al. 
2012). Interestingly, we observed downregulation of transcription factor Myc, master 
regulator of glycolysis. Taken together, these gene transcriptional changes between wild type 
and Twist1 knockout suggest the involvement of Twist1 in synthesis of fatty acids and 
protection of cells against reactive oxygen species, especially lipid peroxidation. Differential 
expression of Myc and Gpx4 has been confirmed by RT PCR (Figure 2-15c). 
Transcriptional data are summarized in Table 4.  
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Figure 2-15: Affymetrix analysis of Twist1 mediated transcriptional expression (figure legend  
continues on the next page): 
(a) Global heat transcriptome map of fold change between repeatedly stimulated Twist1 wild type 
CD4+ T cells (Twist1 wt/wt x OTII) compared to Twist1 deficien  (Twist1 fl/fl x OTII). Green- genes 
transcriptionally upregulated by Twist1, red – genes are transcriptionally downregulated by Twist1 (b) 
metabolic signature of Twist1 depicted as ratio of Affymetrix p obe signal measured in WT vs Twist1 
fl/fl cells (c) RT PCR validation of transcriptional targets Myc and Gpx4, relative to HPRT.  
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2.7 Role of Twist1 in fatty acid metabolism 
Next, we aimed to investigate phenotypic consequence of Twist1 deficiency on metabolism 
in repeatedly stimulated Th1 cells. We hypothesized that Twist1 deficient cells should have 
lover levels of d  novo fatty acid synthesis during activation leading to the lower amount of 
intracellularly stored lipids. 24h after activation repeatedly stimulated cells had significantly 
higher lipid content than once stimulated cells (Figure 2-16a). Moreover, repeatedly 
stimulated Twist1 WT CD4+ T cells had higher lipid content than their Twist1 deficient 
counterparts, as observed by staining with Bodipy 505/515 dye (Figure 2-16a), however the 
difference was not significant (Mann Whitney test: P value= 0,0635). Memory cells were 
shown to be dependent on intracellularly synthesized lipids that are at the same time 
oxidized (Weinberg and Chandel 2014; O'Sullivan et al. 2014). Using metabolic inhibitors we 
investigated functional consequences of decreased lipid content in a repeatedly stimulated, 
Twist1 deficient Th1 cell culture. We tested whether Twist1 deficient cells are capable of 
survival solely on fatty acids, we used specific inhibitor of glycolysis 2DG and concomitant 
inhibition of glutaminolysis by 6-diazo-5-oxo-L-norleucine (DON), excluding glutamine and 
glucose as energy sources.  We observed selective death of three-time activated Twist1-
deficient Th1 cells and not of three-times activated WT Th1 cells. Numbers of WT Th1 cells 
were maintained in vitro at least until day 9 (Figure 2-16b).  
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Figure 2-16: Twist1 mediates survival on fatty acid oxidation: 
(a) Lipid content assessed by BODIPY 505/ 515 staining in once (1W) and repeatedly stimulated (3W) 
Twist1 wild type (WT) and Twist1 deficient (KO) cells. Statistics- MannWh tney test, P value *= 0,0159. 
(b) Absolute cell number of i  vitro  epeatedly stimulated  Th1 cells treated with inhibitor of glycolysis 
(2DG) and concomitant inhibitor of glutaminolysis (DON). Surviving ce l  were count d by CD4+/PI-
gating strategy in FACS. Significance could not be determined. 
2.8 Long term survival is impaired in Twist1 def cient cells upon 
oxidative stress induced by Etomoxir 
 
Differential regulation of several genes involved in oxidative stress protection led us to 
investigate the response of Twist1 deficient cells to the oxidative stress induced by metabolic 
inhibition of FAO by Etomoxir, caused by depletion of NADPH (Estan et al. 2014; Pike et al. 
2011). Using MitoSox Red and Bodipy C11 we measured ROS levels and Lipid peroxide 
levels, respectively, in Etomoxir, 2DG and DON  treated cells.  
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Figure 2-17: Repeatedly stimulated Th1 cells have higher level of ROS and lipid peroxides than 
once activated T cells: 
Once and three times stimulated Th1 cells were re-stimu ated with CD3/CD28 in the absence 
(CONTROL) or presence of metabolic inhibitor of fatty acid oxidation (Etomoxir), glycolysis (2DG) and 
glutaminolysis (DON). Levels of ROS and lipid peroxidation were measured by flow cytometry 
employing staining with  fluorogenic dyes MitoSox Red and Bodipy C11, respectively, 24 and 192 
hours after CD3/ CD28 re-activation. Signif cance was not determined due to a low number of 
replicates. 
  
 
In comparison to other metabolic inhibitors, Etomoxir induced increased levels of 
mitochondrial superoxides in both, once and repeatedly stimulated Th1 cells 24 hours after 
CD3/CD28 re-activation  (Figure 2-17). While ROS levels did decrease in a contraction 
phase (192 hours after activation) Etomoxir treated - three times activated cells had markedly 
higher lipid peroxidation in comparison to once stimulated Th1 cells (Figure 2-17). Lipid 
peroxidation was increased in repeatedly stimulated, Etomoxir treated, Twist1-deficient Th1 
cells on day 7 (168 h a.a.) in contrast to once stimulated, Etomoxir treated, Twist1 deficient 
Th1 cells (Figure 2-18).  
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Figure 2-18: Etomoxir treated three time stimulated Twist1 deficient cells have high levels of 
lipid peroxidation on day 7 after re-activation with CD3/CD28: Accumulation of lipid peroxidation in 
WT and Twist1 deficient cells  treated with selective inhibitors of FAO (Etomoxir) and glycolysis (2DG) 
once (1x) and repeatedly stimulated (3x) CD4+ Th1 c lls determined by C11-BODIPY581/591 (2 µM) 
7days after re-activation with CD3/CD28. Significance could not determined. 
 
Next, we tested if Twist1 deficiency influencs survival of once and repeatedly stimulated 
cells upon Etomoxir- induced oxidative stress. Survival of Twist1 deficient cells is shown as 
ratio of WT surviving cells to Twist1 deficient cells. 3 days after stimulation (d3), control 
medium treated once stimulated Twist1 deficient Th1 cells had survival advantage, assessed 
by cell number ratio of WT (wt/wt)  to Twist1 deficient (fl/fl) cells (Figure 2-19). Etomoxir 
treated/Twist1 deficient/ once stimulated cells were affected by the treatment, nevertheless 
were able to recover - Twist1 deficient cells did survive similarly with or without treatment 
with Etomoxir 7 days after stimulation. Repeatedly activated Twist1 deficient Th1 cells 
cultured in control medium were comparable in su vival to WT counterparts (ratio 1), but 
when Etomoxir was added to the culture, cells survived worst on day 3. Noticably, Etomoxir 
treatment affected long term survival of three times activated Th1 Twist1 deficient cells, as
the cell number was 2x lower than cells grown in control medium. We did not observe this 
effect in repeatedly stimulated Th17 cells (Figure 2-21). 
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Figure 2-19: Three times stimulated Twist1 deficient cells treated with Etomoxir are deficient in 
a long term in vitro survival:  
Twist fl/fl CD4 Cre OTII  and Twist wt/wt CD4 Cre OTII cells stimulated once in vitro for 6 days (grey 
bars) or repeatedly (squared bars ) 18d with OVA peptide, in a presence of splenic APCs under TH 1-
polarizing conditions with  medium control or medium containing 150 μM inhibitor of fatty acid 
oxidation Etomoxir.  CD4+ PI- Cell number of Twist deficient cells is shown relative to WT control and 
was monitored over time by flow cytometer on day 3 and day 7 
 
We were intrigued by deficiencyin survival of Etomoxir treated once activated Th1 cell during 
activation phase, since fatty acid oxidation was not reported to be crucial for effector T cells 
survival during activation. Measurement of glycolysis rates in those cells showed that 
Etomoxir treatment diminished activation induced glycolysis completely in once stimulated 
WT and Twist1 deficient cells (Figure 2-20a) in contrast to control medium cells (Figure 
2-13a). In contrast, chronically stimulated Th1 cells treated with Etomoxir were capable 
increase glycolytic rates (Figure 2-20b).  
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Figure 2-20: Upon treatment with Etomoxir, once stimulated Th1 cells are unable increase 
glycolysis upon addition of glucose and PMA/Ionomycin stimulation: 
Acidification rates (ECAR) of CD4+ CD62Lhi  OTII cells stimulated with OVA peptide under Th1 
polarizing conditions  in vitro for (a) 6 days (once stimulated) or (b) 18 days (repeatedly stimulated) 
days treated with 150 μM Etomoxir. Significance (a) 28 min = 0,4148 (n.s.), 52 min= 0,04 (*); (b) 28 
min = 0,0052 (**), 52 min= 0,012 (*) 
 
 
 
Figure 2-21 Three times stimulated Twist1 deficient Th17 cells are not sensitive to Etomoxir 
induced cell survival defect:  
Cell number ratio of repeatedly stimulated Th17 Twist fl/fl CD4 Cre OTII  to Twist wt/wt CD4 OTII CD4 
Cre cells assessed on day 3 and day 7. Significance was determined by Mann Whitney test as follows.  
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 Materials and methods 
 
3.1 Materials 
 
3.1.1 Mice 
Chimeric conditional Twist1fl/fl mice was produced by Artemis Pharmaceuticals and crossed 
with Cre recombinase driven by CD4 promoter that mediates specific deletion of Twist1 
alleles in CD4 expressing cells. C57BL6/J mie u ed for APC isolation and OVA presentation 
were purchased from the Charles River Laboratories. To obtain mice with transgenic TCR, 
Twist1 fl/fl x CD4 Cre +/- and Twist1wt/wt x CD4 Cre+/- were crossed to OTII mice harbor a 
transgenic MHC class II restricted TCR responding to residues 323–339 of chicken 
ovalbumin. Twistwt/wtCD4-Cre+/- do not harbor loxP sites in the Twist1 locus, us express 
Twist1 and serve as wild type controls. OTII x Twist1fl/fl x CD4 Cre+/- and OTII x Twist1wt/wt x 
CD4 Cre+/- , Twist1fl/fl x CD4 Cre+/- and Twist1wt/wt x CD4 Cre+/- mice were bred in the DRFZ 
animal facility. All mice were housed and bred under specific pathogen-free conditions in 
individually ventilated cages. Mice were handled in accordance with good animal practice as 
defined by the German animal welfare bodies. Al  experimnts were approved by the federal 
state institution „Landesamt für Gesundheit und Soziales“(LAGeSo) in Berlin, Germany.  
3.1.2  Human patient samples 
The samples of peripheral blood and synovial fluid were collected from in total 11 patients by 
Dr. Anne Sae Lim von Stuckrad and Dr. med. Tilmann Kallinich. All children patients with 
Juvenile Idiopathic Arthritis sought medical attention for synovial inflammation at the Charité 
University hospital Berlin in the wake of a flare reaction with joint involvement. The 
medication was follows: 7 patients had no history of medication, 2 patients received 7,5 mg 
of MTX, one patient received Humira 40 mg every 4 weeks and one patient received 
Naproxen. The mean age of the JIA patients was 9,7 years with range 1-20 year.  As part of 
standard relieve measures, synovial fluid was extracted from the knee joint by needle 
aspiration biopsy and collected in an uncoated syringe.  Paired blood was collected 
simultaneously and cells were extracted u ing Ficoll density gradient technology.  
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3.1.3 Instruments 
 
Name  Source  
Cell culture hood Hera Safe  Kendro  
Centrifuge 5810 R  Eppendorf  
Centrifuge Heraeus Multifuge 3S-R  Thermo Scientific  
BD FACSAria II BD Biosciences 
Forceps  Lab Laborfachhandel  
Freezer -80 °C  Th. Geyer  
Fridge 4 °C/ Freezer -20 °C Combi  Liebherr  
Fridge 4 °C/ Freezer -20 °C Combi  Bosch  
Ice machine  Ziegra  
Bacterial incubator, CO2 free Heraeus B6 
Hypoxia iGlove chamber BioSpherix 
Incubator C 150  Binder  
StepOnePlus Real-Time PCR System  Thermo Scientific 
MACS MultiStand  Miltenyi Biotec  
MACSmix™Tube Rotator  Miltenyi Biotec  
MACSQuant Analyzer  Miltenyi Biotec  
Microcentrifuge Heraeus Fresco 17  Thermo Scientific  
Microcentrifuge Heraeus Fresco 21  Thermo Scientific  
MidiMACS™ Separator  Miltenyi Biotec  
Nanodrop-1000  Thermo Scientific  
Pipetboy  Integra  
Pipetboy Easypet 3  Eppendorf  
Pipette Research® Plus 10 µl  Eppendorf  
Pipette Research® Plus 100 µl  Eppendorf  
Pipette Research® Plus 1000 µl  Eppendorf  
Pipette Research® Plus 2.5 µl  Eppendorf  
Pipette Research® Plus Multichannel 300µl  Eppendorf  
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PowerPac™ HC power supply  Bio-Rad  
QuadroMACS™ Separation Unit  Milentyi Biotec  
Scissors  Fine Science Tools  
Seahorse XF e96 Analyzer Agilent Technologies 
ThermoCycler  Biometra  
Trans-Blot® Trubo™ Transfer System  Bio-Rad  
Vortexer Analog Vortex Mixer  VWR  
Vortexer MSI Minishaker  IKA  
Water bath  Memmert  
Zeiss LSM710  Carl Zeiss Microscopy  
3.1.4 Software  
Name  Source  
Adobe Illustrator CC 2015  Adobe Systems  
FlowJo Software version 9.9.4  FlowJo LLC  
GraphPad Prism version 5.04  GraphPad Software  
MACSQuantify™ Software version 2.6  Miltenyi Biotec  
Microsoft Office Standart 2010  Microsoft 
Seahorse Wave version 2.2.0.276 
 
Seahorse Bioscience, Inc. 
3.1.5 Disposable materials 
Name  Source  
0.5/1.5/2 ml reaction tubes Eppendorf 
0.2 ml Thin-walled Tubes with Flat Caps  Thermo Scientific  
0.2 µm filter  Sarstedt  
Cell culture plate 6-well  Greiner Bio  
Cell culture plate 96-well  Greiner Bio  
Cell strainer 70 µm  BD Biosciences  
Cell strainer 100 µm  BD Biosciences  
FACS tubes 5 ml  Carl Roth  
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Falcon tube 15 ml  Ibidi/ BD Biosciences 
Falcon tube 50 ml  BD Biosciences  
Filtered pipette tips 10 µl  Sarstedt  
Filtered pipette tips 1000 µl  Sarstedt  
Filtered pipette tips 20 µl  Sarstedt  
Filtered pipette tips 200 µl  Sarstedt  
Industrial mesh 70 µm pores  Sarstedt  
Kimtech absorbent towels  Sarstedt  
LS separation columns  Sefar Nitex  
Pipette tips 10 µl  Greiner Bio  
Pipette tips 1250 µl  Greiner Bio  
Pipette tips 200 µl  Sarstedt  
Pre-separation filter  Sarstedt  
Reaction tube 0.5 ml  Sarstedt  
Reaction tube 1.5 ml  Miltenyi Biotec  
Reaction tube 2.0 ml  Sarstedt  
Steritop filter  Sarstedt  
3.1.6 Chemicals, reagents, ntibodies for in v tro culture 
Name  Source  
2-Mercaptoethanol  Sigma-Aldrich  
2-NBDG Sigma-Aldrich 
99,9% Ethanol Roth 
Etomoxir Sigma-Aldrich 
2DG Sigma-Aldrich 
DON Sigma-Aldrich 
Anti-mouse CD28 DRFZ 
eCD3 Miltenyi 
Anti-mCD4-FITC, clone: GK1.5  purified in DRFZ 
Anti-hCD4-Cy5, clone: TT1 purified in DRFZ 
Anti-CD4 MultiSort beads Miltenyi 
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Anti-CD62L MultiSort beads Miltenyi 
Anti-CD62L- APC purified in DRFZ 
Anti-CD90.2 MultiSort Beads Miltenyi 
Anti-FITC MultiSort beads Miltenyi 
Anti-IFNἬ clone: AN18.1724 DRFZ 
Anti-IL-4, clone: 11B11 DRFZ 
Anti-HIF1 alpha (ChIP/Western Blot)   Abcam 
Anti-HIF2 alpha (Western blot)   Novus Biologicals 
BD Perm/Wash™ buffer  BD Biosciences 
BODIPY  505/515  Thermo Fisher 
BODIPY  581/591 C11 Thermo Fisher 
Bovine Serum Albumin (BSA) Fraction V  PAN Biotech  
Brefeldin A  BioLegend  
Calibrant Agilent Technologies (Seahorse Inc.) 
Cell Proliferation Dye eFluor™ 670, 
eBioscience™ 
Thermo Fisher 
cOmplete, EDTA-free Roche Applied Science  
cOmplete, Mini, EDTA-free  Roche Applied Science  
Cytochalasin B Sigma 
Cytofix/Cytoperm buffer BD Biosciences 
DAPI  DAPI 
dNTP Mix  Bioline  
EDTA  Sigma-Aldrich  
Ethanol, 100%  Carl Roth  
Ficoll (Histopaque-1083) Sigma 
Ficoll Paque TM  PLUS  GE Healthcare 
Fixable Viablility Dye eFluor 780  eBioscience  
Fetal calf serum (FCS)  Biochrom  
Formaldehyde solution, min 37%  Merck Millipore  
GIBCO ® RPMI 1640 + GlutaMAXTM  Life Technologies 
GIBCO ® RPMI 1640 + GlutaMAXTM  glucose Life Technologies 
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free, with L-Glutamine 
Glycerol  Carl Roth  
Glycine  Carl Roth  
HISTOPAQUE®-1083  Sigma-Aldrich  
IgG1 Fc, recombinant, human  R&D Systems  
Interleukin 12, recombinant, murine  R&D Systems  
Interleukin 2, recombinant, murine  R&D Systems  
Interleukin 6, recombinant, murine R&D Systems 
Interleukin 23, recombinant, murine R&D Systems 
Human serum , male Ab plasma Sigma 
Ionomycin  Sigma  
KCl  Carl Roth  
L-Glutamine Invitrogen  
MgCl Stock 25mM – Tagman Applied Biosystems 
MgCl Stock 25mM – SybrGreen Roche Diagnostics 
MiroTracker® Red CMXRos  Thermo Scientific 
Na2HPO4  Merck Millipore  
Na3VO4 Sigma-Aldrich  
NaF  Sigma-Aldrich  
Penicillin/Streptomycin 100X  Life technologies  
Peptide OVA 323-339  R.Volkmer-Engert, Humboldt University of 
Berlin  
Perm/wash buffer 10x BD 
Poly-D-Lysine hydrobromide Sigma- Aldrich 
PMA  Sigma-Aldrich  
Propidium Iodide Sigma-Aldrich 
RPMI 1640 + GlutaMAX-I  Life technologies  
TGF β R&D Systems 
XF96 Seahorse culture microplate Agilent Technologies 
XF96 four-port sensor cartridge Agilent Technologies 
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3.1.7 List of antibodies used for flow cytometry 
 
Name Clone Fluorochrome Source 
Anti- Mouse CD4 GK 1.5 FITC DRFZ 
Anti-Mouse TNF-α MP6-XT22 PerCP DRFZ 
Anti-Mouse IFN-γ XMG 1.2 PerCP.Cy5.5 eBioscience 
Anti- Mouse IL-2 JES 65H4 eFl450 eBioscience 
Anti- Mouse IL-17A TC11-18H10.1 FITC Biolegend 
Anti- Mouse IL-17F eBio18F10 Alexa Fluor® 647 eBioscience 
Anti- Mouse IL10  JES 516E3 PE eBioscience 
Anti human CD14  TM1  PE DRFZ 
Anti human CD3 SK7 APC Cy7 eBioscience 
Anti human CD4 Okt4 BV 510 Biolegend 
Anti human CD4  SK3 BV421 BD 
Anti human CD4 RM4-5 PE-Cy7 eBioscience 
Anti human CD45RO   Uchl1 FITC DRFZ 
Anti human CD45RA G11 APC DRFZ 
Anti human CXCR5 clone APC Milteney 
anti human IL-2 MQ117H12 BV 605 Biolegend 
anti human IL-4 8D48 PE Biolegend 
anti human IL-21 7H20-I19-M3 Biotin Biolegend 
Anti human IFN-γ 4SB3 Pe- Cy7 Biolegend 
Anti human TNF-α cA2 APC Milteney 
Anti human IL-17 A 64Dec17 Al 488 eBioscience 
Anti human IL-17 A Bl168 APC- Cy7 Biolegend 
Anti human T-bet 4B10 APC Biolegend 
Anti human IL-10 13099223 PE Milteney 
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3.1.8 Buffers and Media 
 
Buffers (reagent)  Final concentration / amount 
PBS buffer In house 
NaCl  137 mM  
KCl  2.7 mM  
Na2HPO4  10 mM  
KH2PO4  1,8 mM  
HCl  Add until pH = 7.4  
PBS/BSA In house 
PBS 500 ml 
BSA 1 g 
PBS/BSA/EDTA In house 
PBS/BSA 500 ml 
EDTA 2mM 
Media Component concentration/ company 
RPMI complete mouse  
GIBCO ® RPMI 1640 + GlutaMAXTM  500ml 
FCS  5ml 
2-Mercaptoethanol 50 mM 500 µl 
Penicillin/Streptomycin  5ml 
RPMI complete human  
GIBCO ® RPMI 1640 + GlutaMAXTM 
(500ml) 
500ml 
Human male Ab serum 5% 
Penicillin/Streptomycin (5ml) 1% 
 
3.1.9 Commercial Kits 
Kit name Source 
Direct-zol RNA kit Zymo research 
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LightCycler® FastStart DNA Master SYBR 
Green 
Roch  
RNeasy Mini Kit Quiagen 
Taqman Reverse Transcription Reagent Kit Life technologies 
 
3.2 Methods 
 
3.2.1 Isolation of primary naïve mouse CD4+ T cells  
To start a culture of once and repeatedly stimulated T helper 1 cells, spleens and peripheral 
lymph nodes were isolated from eight to ten-week-old mice and prepared to single cell 
suspension. Subsequently, cells were washed 2x in PBS/BSA/2mM EDTA and filtered 
through 100 µm and 70 µm cell strainers. Between washes cells were centrifuged at 
1200rpm for 10 minutes. Next, cells were stained by anti-mouse CD4 FITC antibody in 
BS/BSA/EDTA. Following an antibody staining step, cells were washed in PBS/BSA/EDTA 
and resuspended in 90 µl PBS/BSA/EDTA and anti-FITC multisort beads were added in ratio 
1:10, followed by incubation for 20 min in the fridge. After incubation cells were washed in 
PBS/BSA/EDTA and resuspended in 5 ml PBS/BSA/EDTA. Bead-labelled cell suspension 
was applied through a pre-separation filter to a PBS/BSA/ EDTA equilibrated LS separation 
column. The column was washed three times with 5ml BS/BSA/EDTA. CD4+ cells were 
eluted from the column with 7 ml PBS/BSA/EDTA. CD4+ cell suspensions with purity of more 
than 98% were centrifuged and resuspended in 1 ml PBS/BSA/EDTA containing 25 µl of 
release reagent in order to release CD4+cells from the magnetic beads. Following 30 min 
incubation in 4oC, 2 ml of PBS/BSA/EDTA was  added to the release buffer with cells and 
applied to an equilibrated LS separation column to separate magnetic beads from CD4+ cells. 
CD4 + cells were washed out of the column  with 2x 3ml of PBS/BSA/EDTA. Obtained cells 
were counted and resuspended to the end concentration of 100 µl PBS/BSA/EDTA per 107 
cells. To isolate naïve cells, anti-CD62L microboeads were added in a ratio of 1:15 and 
incubated 20 min in the fridge. Following the incubation, cells were washed with 
PBS/BSA/EDTA and resuspended in 5 ml PBS/BSA/EDTA. Suspension was again applied to 
new equilibrated LS separation column to separate CD62L+ cells. Th  column was washed 4 
times with 3ml. Column was removed from the magnet and CD62L+ cells were eluted with 7 
ml PBS/BSA/EDTA. Naïve cell purity was analyzed by flow cytometry after staining with anti-
mouse CD62L APC. Naïve (CD4+CD62L+) cell suspensions with a CD4+CD62L+purity of 
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more than 97% cells were used for T culture. In case of insufficient purity, cells were pulled 
through one more LS separation column.  
3.2.2  T helper cell culture  
 
CD4+ CD62L+ (“Naïve”) T cells and CD4+ T helper cells were cultured at a concentration of 
2,5 x 10 E6 cells/ 5 ml in a 6- well plate using RPMI supplemented with 10% fetal calve 
serum (FCS), 300 µg/ml glutamine, 100 U /ML penicillin, 100 µg/ml streptomycin and 50 µM 
β-mercaptoethanol, at 37 °C and 5% CO2 atmosphere and 4% oxygen, if not stated 
otherwise. If using mice carrying wild type TCR, cells were stimulated polyclonally with anti-
CD3/ anti- CD28. Prior to culture seeding, culture plate was coated with 3 µg/ml anti-CD3 
antibody in PBS for 3 h at 37 °C in 5% CO2. 1,5 µg/ml of soluble anti-CD28 antibody was 
added to the polarizing RPMI medium. To induce Th1-polarization, 5 ng/ml  of IL-12, 10 
ng/ml of IL-2 and 10 µg/ml of anti-IL4 antibody was added to the RPMI medium. To induce 
Th17 polarization 10 µg/ml of α-IFN-γ, 10 µg/ml  of α-IL-4, 20 ng/ml of IL6, 20 ng/ml of IL-23 
and 1 ng/ml of TGFβ was added to RPMI medium. After 48 h of stimulation cells were 
removed from the plate-bound anti-CD3 antibody. Viable Th1 and Th17 cells were harvested 
5-6 days after stimulation via Ficoll density gradient centrifugation for 20 min at 2000rpm. If 
using TCR transgenic OTII mice (Twistfl/flCD4-Cre+/- x OTII/Twistwt/wt CD4-Cre+/- x OTII) 
lymphocytes were stimulated with 1 µg/ml of cognate OVA327-339 peptide that was added to 
culture  polarizing medium. All cell cultural cytokine mixtures were steril-filtered before 
applied to cells. In all cultures, lymphocytes were co-cultured t gether ith irradiated (30 Gy) 
CD90.2 depleted splenocytes as APCs from C57BL/6 mice at a ratio of 5:1. For a repeated 
“chronic stimulation”, viable TH  cells were harvested by Ficoll density gradient centrifugation, 
repeatedly stimulated every 5-6 days under the original conditions 2-3 times.10 ng/ml murine 
IL-2  was added to the culture for second and further stimulation. Small proportions of T cells 
were taken for differentiation control by intracellular cytokine staining (3.2.3) and RNA 
extraction (3.2.4). 
3.2.3  Mitogenic restimulation of T helper cells, intracellular    cytokine 
staining and surface staining  
5 x 105 T helper cells were restimulated by the TCR mimicking reagents PMA (10 ng/ml) and 
Ionomycin (1 µg/ml) for a total of 5-6 hours in growth medium. After 1 h, 5 µg/ml Brefeldin A 
(Bref A) was added to the cells to block exocytosis. After stimulation, cells were washed with 
cold PBS and stained for 15 min in the fridge in PBS containing a fixable live/dead 
discrimination die. Following 2x washing with PBS/BSA, cells were fixed with 
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Cytofix/cytoperm buffer for 20 min at 4 °C. Afterwards, cells were washed once with cold 
PBS/BSA/EDTA. In case of simultaneous staining of transcription factors and cytokines, cells 
were incubated in 0,01% Triton X-100 10 minutes on ice,  washed 1x with Perm/wash buffer, 
than re-fixed with Cytofix/ cytoperm buffer for 5 minutes in RT and washed 1x with BD 
Perm/wash buffer. Cytokines/ surface markers/ transcription factors were stained with 
fluorescently labelled antibodies in 1X BD Wash/Perm buffer for 30 min at RT.  After washing 
with 1X BD Wash/Perm buffer, cells were resuspended in PBS/BSA/EDTA and analysed by 
the MACSQuant Analyser.  
3.2.4  RNA isolation 
To induce Twist1 transcription, cultured cells were re-stimulated with PMA (10 ng/ml)/ 
Ionomycin (1 µg/ml) for 5 hours. Total RNA was isolated with RNeasy kit for transcriptome 
analysis, Direct-zol RNA kit for routine RT –PCR according to manufacturer’s instructions 
and RNA concentration and quality was determined by Nanodrop -spectrometry.  
3.2.5 Reverse Transcription 
200 ng - 1µg of mRNA was reversely transcribed by Taqman Reverse Transcription kit 
according to manufacturer’s recommendations. The reverse transcription reaction consists of 
the following steps:  
 Specific annealing for 10 min at 25 °C,  
 Elongation of complementary DNA (cDNA) for 40 min at 48 °C,  
 Inactivation of Reverse Transcriptase for 5 min at 95 °C. 
 
For each sample the following reaction mix was used: 
 Concentration µl / sample 
Oligo dT Primer 10 mM 0.5 
Random Hexamer Primer 10 mM 0.5 
dNTPs 25 mM 4 
Reverse Transcriptase 50 U / μl 0.5 
RNAse inhibitor 20 U / μl 0.4 
RT buffer 10x 2 
MgCl2 25 mM 4.4 
RNA sample  7.7 
  20 μl 
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3.2.6  Quantitative Real Time PCR 
Quantitive RealTime-Polymerase Chain Reaction (qRT-PCR) was used to determine the 
specific amount of the mRNA of interest at a distinct time point by means of fluorescent 
signal intensity. For normalization the gene expression to the total mRNA, target gene values 
were compared to values of mRNA for HPRT. SybrGreen-qRT-PCR method have been used 
for for mRNA detection. 
The qRT-PCR reaction consists of the following steps: 
 10 min at 95 °C : initial polymerase activation 
 10 sec at 95 °C :denaturation 
 10 sec at primer specific temperature (see Table 1 ): annealing 
 10 sec at 72 °C : elongation 
 
For quantitation, cDNA was diluted 5x and used in the following reaction mixture: 
 Concentration µl / sample 
cDNA  1 
Forward primer 5 µM 0.25 
Reverse primer 5 µM 0.25 
SybrGreen reaction mix n. a. 0.5 
MgCl2* 25 mM Depending on primer pair 
RNAse-free Water  Depending on primer pair 
  10 μl 
* MgCl2-concentrations have been determined during primer establishment (see Table 1) 
 
 
Table 1 : Primer sequences of target gens, annealin  temperature and MgCl2 concentration 
 
Gene - primer pair Forward primer (fw) Reverse primer (rv) Annealing 
T
MgCl2
HPRT (mouse) tcctcctcagaccgctttt cataacctggttcatcatcgc 65°C 3 mM 
HPRT (human) accctttccaaatcctcagc gttatggcgacccgcag 60°C 3mM 
Twist1 (mouse) 
111( 1 )
cgcacgcagtcgctgaacg gacgcggacatggaccagg 65°C 2 mM 
Twist1 (human) ggcacccagtcgctgaacg gacgcggacatggaccagg 65°C 2 mM 
Bim (mouse) cccggagatacggattgca aacaccctccttgtgtaagtttcgt 60°C 2 mM 
IL10 (mouse) aggcgctgtcatcgatttct ggcc tgtagacaccttgg 60°C 4mM 
PRDM1(mouse) gacgggggtacttctgttca ggcattcttgggaactctct 60°C 3mM 
Materials and methods 
 
65 
 
Trp53inp1(mouse) actcacgggcacag aatgg gggcgaaaactcttgggttg 60°C      3mM 
Bnip3(mouse) gaagcgcacagctactctca tccaatgtagatccccaagcc 60°C      4mM 
P2X7R(mouse) aggccaagaagttccaaccta tccattgagagcatggcttctt 60°C      4mM 
Bcl6(mouse) ctgtgaaatctgtggcactcgc cagcggccgacacgcggtattgc 60°C      3mM 
PD-1(mouse) cgtccctcagtcaagaggag gtccctagaagtgcccaaca 60°C      4mM 
Glut3(mouse) tgtaggacccgaggaacact gatggggtcacct cgttgt 60°C      4mM 
Glut1(mouse) Gtgacgatctgagctacggg tcaccttcttgctgctggg 60°C      4mM 
Pdk1(mouse) tgcgacaa gttgcctgtt ggctttggatataccaactt gcac 60°C      2mM 
ICOS(mouse) aaacaacccagacagctccc gcagcagagctgggattcata 60°C      4mM 
Myc(mouse) ttgaaggctggatttcctttgggc cgt gcagatgaaatagggctgt60°C      3mM 
PRDM1(mouse) gacgggggtacttctgttca   gcattcttgggaactgtgt 60°C      3mM 
Gpx4(mouse) acctggacgccaaagtccta ggctgagaattcgtgcatgg 60°C      3mM 
 
Primers were synthesized by and purchased from TIB Molbiol Berlin. 
3.2.7 Glucose uptake assay 
Viable T helper cells were harvested by Ficoll den ity gradient centrifugation and washed in 
PBS/BSA. Subsequently, cells were seeded into a 96-well plate coated previously with 3 
µg/ml of anti-CD3 in concentration 3x10 E5 cells per well and stimulated with for a 5 h in a 
RPMI complete Th1 polarizing medium with soluble 1,5 µg/ml of anti- CD28, as described in 
the section 3.2.2. After the incubation, cells were centrifuged down, medium was aspirated 
and 100uL of glucose-free RPMI Th1 media with 1,5 µg/ml of soluble anti-CD28 antibody 
was added to the cells and incubated for 60 minutess. After incubation, solution of 100 uL  of 
glucose-free RPMI with 300uM of 2-((7-nitro- ,1,3-benzoxadiazol-4-yl)amino)-2 
deoxyglucose (2-NBDG) was added to the well to reach concentration of 150 μM. 
Cytochalasin B has been shown to inhibit GLUT1, 2, 3 and 4 and therefore block transport of 
glucose to the cell. Therefore, well with no 2-NBDG and well with 150uM  of 2-NBDG+ 30 µM 
Cytochalasin B were used as controls. Cells were incubated for 30 minutes at 37oC. After 
incubation, cells were washed 2x in the PBS with centrifugation 1200 rpm, resuspended in 
PBS and maintained at 4 oC. Data were acquired by measurement of fluorescence in FL-
1/FITC channel immediately using a flow cytometry after exclusion of dead cells by PI 
staining. 
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3.2.8  Seahorse  Assay 
 
Oxidative phosphorylation and glycolysis can be estimated relat vely easily and quickly from 
the rates of linked reactions: extracellular acidification resulting from glycolytic conversion of 
uncharged glucose to 2 lactate− plus 2 H+ and oxygen consumption to oxidize substrates 
such as glucose and fatty acids to support oxidative phosphorylation.  Seahorse XP analyser 
can measure both of output reactions. Viable T helper cells were harvested by Ficoll density 
gradient centrifugation and washed in PBS/BSA. Subsequently, cells were washed 3x with 
glucose free RPMI assay media, pH 7,35,  and seeded in the density of 2 x10 E 5 cells per 
well in 180 μl glucose free RPMI, culture medium (pH 7,35) onto an XF96 Seahorse culture 
microplate which was coated a day in advance for 2 h in RT with 13 µL of 100µg/ml Poly-D-
Lysine solution per well and washed 2x with 500 µL of ddH2O. No cells were plated in the 
four edge rows.  Prior to the assay, cells were put for 90 minutes into 37°C incubator without 
CO 2. In the meantime assay compounds were prepared as indicated in Table 2. Chemicals 
were diluted in Seahorse assay medium and were loaded to the ports of the equilibrated 
XF96 four-port sensor cartridge. Acidificat on rate (ECAR) and consumption rate was 
monitored over time for 180 min  with injection of glucose after 15min, and  injection of 
PMA/Ionomycin at 35 minute. Assay was performed in 21% oxygen.  
 
 
Table 2 Compounds used for Seahorse assay: 
Compund Port Stock conc Conc. In port Volume in 
port 
Conc. On cells 
Glucose A 1M 100 mM 20 µL 10mM 
PMA/Iono B 1mg/ml 10 µg/ml Iono 
100ng/ml PMA 
 
22 µL 10 ng/ml PMA 
and 1 µg/ml 
Ionomycin 
 
3.2.9 Metabolic survival assay 
 
 Mouse T cell culture 
Viable CD4 T helper cells were harvested by Ficoll density gradient centrifugation and 
washed in PBS/BSA. 96-well plate was coated with 3 µg/ml  anti-CD3 for 3 hours at 37°C. 
Cells were plated in complete RPMI medium with 1,5 µg/ml soluble anti-CD28  and 
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polarization cytokines plus inhibitors listed in Table 3. Cell number was monitored over time 
in 2 day interval using exclusion of dead cells with 100 ng/ml  of Propidium Iodide or 100 
ng/ml of DAPI  dye. Detection was done by flow cytometer.  
 
 Human T cell culture. 
 
Synovial fluids were taken by puncture of joints of patients suffering from juvenile idiopathic 
arthritis. At first, synovial fluid was centrifuged with rotational speed 1500 rpm. Cells were 
resuspended in PBS/EDTA and depleted of CD14+ cells using 2x MACS column and anti-
CD14 magnetically labelled antibody. Sorted CD4+ T cells wer  plated in RPMI medium 
containing a human serum, antibiotics and inhibitors to monitor cell number over time using 
CD4 antibody and DAPI. Proliferation was monitored by plating equal number of cells 
labelled with Cell Proliferation Dye eFluor™ 670 (eBioscience). To detect cytokines, CD4+ 
CD14- cells were re-stimulated by PMA/Ionomycin for 5,5 hours, BreA was added 1 hour 
after initial stimulation. Cells were fixed according to protocol described in 3.2.3. Paired blood 
was taken from diseased donors as a control and processed identically, except the cells 
were first isolated by density gradient separation using Ficoll. Synovial and control cells were 
than FACS sorted by surface expression of CD3+ CD4+ CD14- CD45RO + PD1+ and CD3+ 
CD4 + CD14- CD45RO +  PD1- cells to two groups. Cells from two cell groups were plated in 
identical cell number (1,5  x10E5 per 96 well- plate) in a complete control medium or 
complete medium containing 150µM Etomoxir. Cell number was counted over time using 
MacsQuant. Dead cells were excluded using DAPI. To isolate RNA, sorted cells were 
washed in PBS and lysed in Zymo lysis buffer for RNA extraction described in section 3.2.4. 
 
Table 3- Chemical inhibitors of metabolic pathways 
Inhibitor Final 
concentration 
Inhibited catabolic 
pathway 
DON 50µM glutaminolysis 
2-deoxyglucose 2 mM glycolysis  
oligomycin 2 µM OXPHOS 
Etomoxir 150 µM Fatty acid oxidation 
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3.2.10 Global transcription analysis of Twist1 target  by microarray      
assay 
Transgenic TwistloxP/loxP  OTII and  Twist1 wt/wt x OTII murine naïve T cells were cultured 
under Th1 polarizing conditions for 4 rounds of stimulation (Figure 3-1). TAT – Cre was 
added on day 21 of the culture. TAT - Cre was  purified in advanced by Large Scale 
Purification Under Native Conditions using protocol described by (Peitz et al. 2002). TAT-
CRE is a recombinant cell-permeant fusion Cre - recombinase protein consisting of TAT 
sequence and a nuclear localization sequence (NLS). It catalyzes the site specific 
recombination event between two loxP DNA sites. Cells were isolated and cultured as 
described in paragraph 3.2.1 and 3.2.2. Culture was performed under 21% oxygen levels. 
 
 
 
 
Figure 3-1 Schematic overview of the steps involved in gene expression profiling of Twist1 
deficient repeatedly stimulated T cells: 
CD4+ CD62Lhi  cells were stimulated in vitro for 4 rounds of stimulation (lasting 6 d each) under TH 1-
polarizing conditions, with splenic APCs and ova327-339 , On day 21(day 3 after re-stimulation), 
synthetic CRE with attached nuclear localization signal was added to he culture. On day 24, life cells 
were collected and re-stimulated for 3,5h with PMA/Ionomycin. RNA was isolated using RNeasy Mini 
Kit (Quiagen). 
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Purified RNA of Twist1 Th1 deficient cells (Twist1 loxP/loxP x OTII ) and control  Twist1 wt/wt x
OTII cells was hybridized to Affymetrix GeneChip® Mouse Genome 430 2.0 arrays according 
to the manufacturer’s instructions by Heidi Schliemann.  The 10 μg of RNA of the cells of 
interest is isolated, reverse-transcribed to cRNA, labeled and incubated with the array. 
Arrays contain spots of short oligonucleotides representative of the coding regions of all 
genes. Complementary sequences hybridize and the amount of hybridized RNA is later 
quantified by fluorescence detection. Dr. Joachim R. Grün analyzed differentially regulated 
genes. 
 
3.2.11 Lipid peroxidation 
  
BODIPY 581/591 C11 (4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-
indacene-3-undecanoic acid) was added to T cells treated with metabolic inhibotors in 96well 
plate at a final concentration of 3 µM inhibitor in RPMI,  serum/β-Me/FREE  medium and
allowed to incubate for 40 min at 370C. The cells were washed in PBS/BSA. Dead cells were 
excluded by DAPI staining and live cells were assessed using an MACS Quant flow 
cytometer. Excitation was achieved with an argon laser (488 nm). Green fluorescence was 
detected with an FL1 band pass (BP) filter 530/30.Data were collected from a minimum of 50 
000 cells. 
 
3.2.12 Lipid content  
To measure lipid content 250,000 cells were plated onto a 96-well plate in quintuplicates  
resuspended in conditioned serum/β-Me containing medium, 37oC. At the time point of the 
measurement 50µl aliquot was removed for st ining with 400nM Bodipy 505/515 into 
serum/β-Me/FREE conditioned medium and incubated 40´ 37oC. Next, cells were washed 
and resuspended in cold PBS/BSA and measured DAPI negative cells for FL1 fluorescence. 
3.3  Statistics 
All statistical analyses used the Mann-Whitney-Test for unpaired data, unless stated 
otherwise. A P value of equal or less than 0.05 was considered significant. 
 
 
 
Discussion 
 
70 
 
 Discussion 
 
 
Rheumatic diseases significantly affect patient´s life.  Throughout progression of an 
autoimmune synovial arthritis, formation of ectop c lymphoid structures supports amplification 
mechanisms that serve to sustain the lifelong inflammatory process (Humby et al. 2009). 
Within those structures, CD4+ T cells are particularly harmful as they are potent drivers of 
autoimmune response (Rao et al. 2017a), resisting therapeutic intervention (Eggleton et al. 
2010; Scott et al. 2010). Resistance to cell death likely results from collection of factors, such 
as interaction with synovial stromal cells (Salmon et al. 1997) or downregulation of pro-
apoptotic factor Bim (Haftmann et al. 2015). Nevertheless, metabolic adaptation as a mean 
to survive is merely studied. As a repeated stimulation is associated with acquisition of 
properties towards pathogenic phenotype (Lee and Lee 2016), we reasoned that differences 
in the duration of antigen stimulation could alter the metabolic phenotype. Changes 
introduced by repeated stimulation involve CD28 downregulation or upregulation of PD and 
CTLA4 surface molecules (Walker 2017). These markers are associated with metabolic 
switches (Patsoukis et al. 2015; Frauwirth et al. 2002). For the first time, we explore 
metabolic properties of in vitro rpeatedly stimulated Th1 cells. Observed phenotype in this 
model was subsequently translated to metabolism of CD45RO+ CD4+T cells isolated ex vivo 
from auto-inflamed synovial fluid of Juvenile Idiopathic Arthritic patients. RNA analysis 
revealed that the pathogenic subset (CD45 RO + CD4+ CXCR5- PD1+) of synovial CD4+ T 
cells express higher levels of transcription factor Twis 1, hallmark of pathogenic Th1 cells.  
Cytokine secretion from CD4 T cells in synovial enviro ment appears to be low (Firestein 
and Zvaifler 2002). Furthermore, Twist1 is elevated in biopsies of patients that are both 
treated and un-treated with immunosuppressive therapy. This suggests that cytokine 
inhibition, previously described function of Twist1 in Th1 cells, might not be the main one in 
the inflammatory milieu. Twist1 functions as a regulator of energy homeostasis and fatty acid 
metabolism in adipocytes (Pan et al. 2009; Pettersson et al. 2010) and therefore we explored 
role of Twist1 in metabolism strategy of CD4 T cells that survive and persist in the inflamed 
tissue.  
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4.1 Chronically activated Th1 cells adapt to more efficient 
metabolic pathway  
 
Throughout development, T cells present high flexibility in navigation of their metabolic 
programs according to their immediate needs. This abili y to adapt is retained during their  
life cycle (Blagih et al. 2015; Weis et al. 2017). Although immune cells spend significant 
amount of time in the blood, where nutrients are relatively abundant, inflamed synovial 
environment of rheumatoid joint lacks blood supply due to a defective vascularization and 
oedema, leading to a low levels of oxygen and nutrients (Maciolek et al. 2014). Energy 
demands for inflammatory CD4+ T cells are energetically challenging and therefore cells 
need to adjust their metabolism to survive. To address metabolic adaptations to chronic 
stimulation in a nutrient depleted environment, we first employed an in vitro model of 
chronically stimulated Th1 cells using murine CD4 T lymphocytes (Figure 2-1). Murine Th1 
cells were co-cultured for several rounds of stimulation together with an antigen presenting 
cells. In order to imitate the in vivo conditions as closely as possible, we cultured cells in 4% 
oxygen. Upon repeated stimulation, Th1 cells decrease glucose uptake (Figure 2-2) and 
decrease their glycolytic levels (Figure 2-3). However, cells still retain residual glucose 
uptake in comparison to blocked control (Figure 2-2). Residual carbon intake is not only used 
for cytokine production and homeostatic proliferation (Tripmacher et al. 2008), but 
importantly, for synthesis of triacylglycerides (TAG). TAG are necessar  for memory survival 
(Cui et al. 2015). Decrease of glycolytic metabolism connected to a repeated stimulation of 
CD4 T cells has been observed previously in graft versus host disease (GVHD), where lower 
glucose uptake was associated with decrease of CD28 expression (van Baarle et al. 2005). 
Cells metabolism shifted towards fatty acid oxidation (Byersdorfer et al. 2013). Therefore, we 
tested how glycolytic and oxidative phosphorylation rates change with repeated stimulation in 
Th1 cells.  
CD4 T cells in memory or chronic (auto-) inflammatory diseases must often endure long 
period of quiescence and nutrient (and glucose) depleted environment. How Th1 cells 
respond once glucose is not available? If Th1 cells lost access to extracellular sources of 
glucose, three times stimulated Th1 cells had higher oxidation levels than their once 
stimulated Th1 counterparts (Figure 2-3b). This is an indicatiton, that CD4 memory T cells 
employ similar mechanism as CD8 T cells. CD8 memory T cells store intracellular lipid 
reserves that are oxidized  as a energy source for survival (Michalek et al. 2011).  
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However, it should be noted, that glycolytic rates of cells that lost an access to extracellular 
sources of glucose were slightly, but significantly higher also in resting repeatedly stimulated 
cells.  It remains to be investigated what could be a source of such acidification. CO2
generated in active TCA is a source of hydrogen protons which might cause the acidification 
of a medium. However, no data are available at the moment and the exact cause remains to 
be found.  
If glucose is available to cells, glycolysis was lower in repeatedly stimulated Th1 cells than in 
once stimulated than (Figure 2-3c), indicating that repeated stimulation induces a switch in 
metabolism. Optimisation of metabolism towards actual energy needs is logical: while 
glycolysis secures 2 molecules of ATP per oxidized glucose,  per one molecule of palmitic 
acid oxidation secures 129 molecules of ATP. The oxygen consumption was higher 
repeatedly stimulated T cells than once stimulated cells, indicating increased capacity of 
repeatedly stimulated cells to oxidize its substrates after repeated stimulation in both resting 
and activated phase (Figure 2-3).  
Previously effector T cells were found to be dependent in survival, cytokine secretion and 
cytokine production on glucose utilization (Michalek et al. 2011; Yaqoob and Calder 1997; 
Chang et al. 2013). Observed lower levels of glucose uptake and lower glycolytic levels in 
repeatedly stimulated cells led us to investigate how survival is affected if glucose is limited. 
We hypothesized that decreased level of glycolysis and glucose uptake mean metabolic shift 
towards fatty acid oxidation. To this end, we measured survival in glycolysis and fatty acid 
oxidation - limiting conditions (Figure 2-4).  Repeatedly t m lated Th1 cells were significantly 
less dependent in survival on glucose than were their once stimulated counterparts (Figure 
2-4a). Accordingly, a long term of in vitro survival of repeatedly stimulated CD4 Th1 cells is 
completely abolished if cells are treated with fatty acid oxidation inhibitor Etomoxir (Figure 
2-4b). Interestingly, repeatedly stimulated cells treated with Etomoxir had higher survival on 
day 2 and day 3. This is possibly due to the cell metabolic flexibility -  higher glucose 
utilization is forced by inhibition of fatty acid oxidation (Figure 2-4c). PD-1 mediates oxidation 
of fatty acids (Patsoukis et al. 2015) and is upregulated in GVHD cells, that are dependent on 
fatty acid oxidation. Accordingly, we measured pd-1 mRNA expres ion (Figure 2-5) in 
repeatedly activated Th1 cells and in contrast to once activated Th1 cells, pd-1 mRNA 
expression was increased. Altogether, results in section 2.1 confirm ability of CD4 + T 
lymphocytes to adapt to chronic stimulation in vit o. In th s experimental set-up, phenotypic 
characteristics that were acquired throughout a long term in vitro culture did not allow a long 
term utilization of glycolysis as cells treated with FAO inhibitor Etomoxir did not survive after 
day 3 (Figure 2-4b) indicating high dependency of repeatedly simulated Th1 cells on FAO. 
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4.2 ex vivo JIA autoimmune CD14- CD4+ T cells secrete IFN-γ 
and prefer oxidative metabolism for survival 
In order to translate murine in vitro studies to an autoimmune rheumatoid disease, we took 
synovial punctate from Juvenile Idiopathic Arthritis (JIA) patients. JIA is the most common 
form of persistent arthritis in children. Even if he cause of disease are not fully disclosed and 
there exist several subtypes (see section 1.3 for detailed description) chronic adaptive 
immune responses are involved in the pathogenesis, as indicated by the presence of T and 
B lymphocytes infiltrating the synovial membrane of inflamed joints (Murray et al. 1996) and 
share many similarities with rheumatic arthritis. T-cell infiltr tes, n both rheumatic arthritis 
and juvenile idiopathic arthritis, predominantly con ist of CD4+Th1 cells which have been 
thought to have a central role in the pathogenesis of the disease (de Jager et al. 2007) while 
Th17 subset presence is still debated (Miossec 2011). Th1 phenotype present in the 
inflamed tissue of RA patients is also supported by the presence of IFN-γ-secreting CD4+ T
cells in the synovium of patients with RA (Nanki and Lipsky 2000). In order to investigate the 
phenotype of CD4+ T cells, we isolated out of the synovial JIA punctate CD14 - CD4+T cells 
and stained them for surface expression of effector and memory markers CD45 RA and 
CD45 RO. Than, we re-stimulated CD14- CD4+T cell with PMA/ Ionomycin in 4% oxygen, as 
hypoxic oxygen tension has been measured in synovial joint (Gaber et al. 2009), 
Flow cytometry showed that majority of T cells have memory (CD 45 RO+ CD45 RA-) 
phenotype, in contrast to the T cells obtained from patients’ blood (Figure 2-6), reflecting past 
or present TCR stimulation. In accordance with previous studies (de Jager et al. 2007), after 
PMA/ Ionomycin restimulation, CD4 T cells expressed IFN-γ and TNF- α and minimum of 
IL17A, reflecting prevalence of Th1 associated cytokine imprinted genes. Of note, other IL17 
family members, particularly IL17F have not been measured, so possibility of a IL17 isoform 
is not excluded. In average 9% of IFN-γ expressing cells also co-expressed IL10 (Figure 
2-7b), induced as a compensatory mechanism of Th1 ells in chronic immune response to 
alloantigen’s (Anderson et al. 2007; Roncarolo et al. 2006) to induce peripheral tolerance. 
Supportive of Th-1 phenotype, CD14- CD4+ CD45 RO+ T cells isolated from synovial fluid 
had higher T- bet expression than CD14- CD4+ CD45 RO+ or CD14- CD4+ CD45 RO- T 
cells isolated from patients’ blood (Figure 2-7c).  
To address metabolic properties of these cells, we were interested in how isolated cells 
response to metabolically challenging environment. We measured increased PD-1 
expression in CD45 RO+ CD4+ CD14- T ex vivo isolated cells from JIA patients in contrast to 
the patients´ blood (Figure 2-8). Interestingly, stimulation with PMA/Ionomycin did not 
Discussion 
 
74 
 
influence expression of PD1, suggesting that cells might be upon isolation in activated state. 
As CD4 T cells expressing PD-1 have been shown to shift preferred metabolism towards 
fatty acid oxidation in in vivo models of GVDH and in murine in vitro model of ubiquitous 
antigen exposure(Byersdorfer et al. 2013), we employed metabolic inhibitors of glycolysis, 
glutaminolysis and fatty acid synthesis to determine surv val sensitivity to metabolic 
inhibition. In contrast to a CD4 T cells isolated from blood, CD14- CD4+ T cells isolated from 
synovial fluid of JIA patients survive a long period of time in in v tro culture (Figure 2-9), 
suggestive of their robust survival potential. Even though cells in ex vivo culture proliferated 
very little (Figure 2-10), stimulation with CD3/CD28 was critical for survival after day 4 (Figure 
2-9b) of the in vitro culture. Two days after activation anti-CD3/anti-CD28 stimulated and un-
stimulated synovial CD4+ CD14- T cells treated with glycolysis inhibitor 2DG had on average 
20% lower survival than control cells (Figure 2-9b),  pointing towards glycolysation 
metabolism in the activation phase if glucose is available. Nevertheless in a long term 
survival, synovial CD4 T cells were most sensitive to inhibition of fatty acid synthesis and 
oxidative phosphorylation (Figure 2-9b, Day 8, anti-CD3/anti-CD28). Collectively, these data 
indicate that synovial CD4+ T cells do employ different metabolic pathways in different 
stages of activation to supply energy and biomolecu es for survival, homeostatic proliferation 
and cell renewal. 
4.3 PD1+ CXCR5- can be selectively eliminated by fatty acid 
oxidation inhibitor Etomoxir in vitro 
Peripherally expanded cell population of CD4+ CD45RO + CXCR5- PD1+ T cells have been 
shown to drive inflammation by providing B cell i struction via stimulatory signals such as IL-
21, CXCL13, ICOS and MAF (Rao et al. 2017a). Due to its pathogenicity, these cells are 
unique targets to reduce inflammation. Any potential therapeutic interventions to relieve the 
inflammation require cell specificity or at least a higher degree of sensitivity. To study 
sensitivity of synovial CD4+ CD45RO + CXCR5- PD1+ T cells to metabolic inhibition, we 
sorted out and cultured CD4+ CXCR5- PD1+ from CD4 + CXCR5- PD1- cell populations in 
the presence or absence of fatty acid oxidation inhibitor Etomoxir (Figure 2-11). CD4 + PD1+ 
CXCR5- T cells cultured in a control medium had 60% survival rate in comparison to 20% 
survival rate of CD4 + CXCR5- PD1- cells, pointing to the survival advantage of PD1+ T 
cells. This might indicate, that PD-1, which is overexpressed in synovial cells from patients 
with rheumatic arthritis, might protect autoreactive T cells from undergoing apoptosis (Lin et 
al. 2004; Wan et al. 2006). To show this, we added Etomoxir to the culture. We were able to 
eliminate survival advantage of PD1+ T cells. C lls were unable to survive till day 4, in 
comparison to CD4+ CXCR5- PD1- cells, that had comparable survival rates on day 4 in 
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Etomoxir containing medium as in control culture (Figure 2-11). Evidence of selective 
inhibition of pathogenic CD4+ CXCR5- PD1+ expanded population with Etomoxir is a 
promising initial experiment that will be expanded to both in vitro PD-1 b ocking or stimulation 
with PD-1 ligand with visualization of active intracellular signalling molecules and 
transcription factors.  
 
4.4 CD4 + CD45 RO+ PD1+ CXCR5- cells express Twist1 that 
mediates inhibition of metabolic activation 
We have previously shown that expression of transcri tion fact r Twist1 is increased in cells 
isolated from inflamed rheumatoid joints (Niesner et al. 2008). Twist1 has been shown to 
induce microRNA148a, which regulates expression of the proapoptotic protein Bim 
(Haftmann et al. 2015) and therefore supporting cell persistence of repeatedly “pathogenic” 
CD4 T cells.  By means of transcriptional analysis we show that CD4+ CD45 RO+ PD1+ 
CXCR5- cells isolated from JIA patients expresses higher mRNA levels of Twist1 than their 
CD4+ CD45 RO+ PD1- CXCR5-  counterparts (Figure 2-12). What is a role of Twist1 in 
pathogenic synovial CD4 T cells? It has been shown hat T c ll  receiving PD-1 signals 
decrease glycolysis and enhance FAO, which dampens their effector function while 
promoting longevity. Does Twist1 contributes to this phenotype? Twist1 was shown to be 
involved in a regulation of metabolism in diverse tissue cell types, such as brown adipose 
tissue cells, white tissue adipose cells or skeletal muscle cells. In brown adipocytes Twist1 
acts as a negative feedback regulator of PPAR-δ /PGC1α signalling, major regulators of 
energy, glucose and fat metabolism (Maruyama et al. 2016). Twist1 inhibits dissipation of 
energy produced by oxidation in form of heat (Pan et al. 2009). In white adipose tissue 
Twist1 positively regulates fatty acid oxidation and anti-inflammatory function (Dobrian 2012; 
Pettersson et al. 2011). In muscle cells, Twist1 regulates glycogen storage (Mudry et al. 
2015b). To address Twist1 metabolic function in repeatedly stimulated Th1 cells, we used 
CD4 conditional Twist1 deficient mice. Since Twist1 protein expression in lymphocytes peaks 
5 hours after activation (Niesner et al. 2008), we aimed our focus on metabolism of 
repeatedly stimulated cells in this time frame when cell increase its glycolytic rates. To this 
end, we measured acidification rates (surrogate marker of glycolysis) and oxidative 
consumption (surrogate marker of oxidative phosphorylation) using Seahorse XP analyser in 
once and repeatedly stimulated /control Twist1 wild type and Twist1- deficient Th1 cells. 
Results indicate that Twist1 downregulates glycolysis in both resting Th1 and resting Th17 
cells. After activation with PMA/ Ionomycin downregulation is specific to once and repeatedly 
activated Th1 cells (Figure 2-13a,b), not Th17 (Figure 2-13c). Oxidative phosphorylation was 
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also downregulated by Twist1 in both once and repeatedly stimulated Th1 cells (Figure 
2-13d,e), with higher downregulation of oxidative consumption in three time stimulated Th1 
cells. This effect was not observed in Th17 cells (Figure 2-13f). Even though the glycolysis  is 
a major pathway, OXPHOS is still active - significant portion of glycolytic derived pyruvate is 
oxidized in mitochondria during T cell activation. Therefore, it is plausible that higher levels of 
oxidation in Twist1 deficient cells are caused by increased level of gl colytic derived pyruvate 
entrance to TCA cycle.  Indeed, if cells are forced to increase glycolytic rates due to an 
inhibition of fatty acid oxidation by Etomoxir, we observed enhanced difference in glycolysis 
between WT and Twist1 deficient cells (Figure 2-20b). In summary, Twist1 appears to inhibit 
metabolic activation, which supports its inhibitory properties on cytokine expression upon 
activation (Niesner et al. 2008), because metabolism is tightly interconnected with cytokine 
expression. Glycolytic intermediate GAPDH, if not engaged in glycolysis, binds to an IFN-γ 
promoter and inhibits IFN-γ expres ion (Chang et al. 2013).  
4.5 Transcriptional profile of Twist1 defici nt cells suggest role 
in activation anabolism and protection against oxidative 
species in repeatedly stimulated Th1 cells 
 
In order to get further insight into Twist1-mediated transriptional regulation of three time 
stimulated Th1 cells, we cultured transgenic OTII Twist1wt/wt anf Twist1fl/fl for 4 rounds of 
stimulation. 3 days before last re-stimulation, recombinant Tat-Cre protein was applied to the 
culture (Figure 3-1). This strategy omits secondary effects of a long-term culture of Twist1 
deficient cells. We observed relatively low number (73) of differential regulated genes. We 
observed no Th1 specific cytokine genes regulated by Twist1. This is in contrast to once 
stimulated cells, where Twist1 regulates gene expression of several Th1- associated 
cytokines such as IFN-γ, TNF-α and IL-2 in Th1 cells (Niesner et al. 2008; Pham et al. 2012). 
This finding was confirmed by flow cytometry measuring cytokine expression in three times 
stimulated Twist1 deficient and WT confirmed this finding (Figure 2-14). These unexpected 
results likely originate from repeated stimulation that require overall change in global 
transcriptome and therefore also change availability of protein binding co-factors, which are 
determining Twist1 function (Qin et al. 2012). Limitation of artificial in vitro culture 
environment also needs to remain considered, as up t  98% of repeatedly stimulated T cells 
secrete IFN-γ, which is not observed in cells isolated ex v vo and/or re timulated polyclonally 
with anti-CD3/anti-CD28. Twist1 has been shown to be functional also in effector Th17 cells 
and TFH  cells, where its expression is induced by STAT3. However, Twist1 expression is not 
upregulated by repeated stimulation of Th17 or Th2 cells, in contrast to Th1 cells, suggesting 
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that alternative function might develop with repeated stimulations. Therefore, Twist1- 
mediated suppression of cytokines might not be as r levant in repeatedly stimulated Th1 
cells as in effector T cells. Interestingly, we observe several differentially expressed genes 
that are also regulated by master transcription factor Bcl6 such as I os, Tnfsf9 (coding for 
41BBL), IL21 are downregulated by Twist1. This is interesting, because PD-1 expressing 
follicular T helper cells, where Twist1 is induced by S AT3, Twist1 acts as limiting factor in 
the development of cell-mediated and humoral immu ity (Pham et al. 2013). Concurrently, 
pathogenicity of peripherally expanded cell population CD4+ CD45RO + CXCR5- PD1+ T 
cells have been shown to drive inflammation by providing B cell instruction via stimulatory 
signals such as IL-21, CXCL13, ICOS and MAF (Rao et al. 2017a). Therefore it is possible, 
that “new” protective function of Twist1 in repeatedly stimulated Th1 cells is to inhibit this 
presentation. Protective suppression of B cell in truction in synovial CD45RO+ CD4+PD1+ 
CXCR5- synovial T cells Twist1 might be another contributing factor to the inflammatory 
phenotype observed in animal model of arthritis treated with small hairpin RNA against 
Twist1 (Niesner et al. 2008). 
Another two sets of differentially regulated genes were genes with reported function in 
apoptosis and metabolism. We observed upregulation of Bnip3. Its anti-apoptotic function 
stems from its metabolic regulation of mitochondria autophagy after activation induced 
release of BH3 factors, such as Bim, that mediate caspase induced cell death (Kroemer and 
Reed 2000). Cells expressing Bnip3 elude cell death by upregulating mitochondrial 
autophagy coupled with ROS scavenging. Lysosomal degradation of mitochondria further 
promotes cell survival (O'Sullivan et al. 2015; Moriyama et al. 2017). Further, Bnip3 has been 
shown to promote oxidation of fatty acids and maintaining mitochondrial integrity (Glick et al. 
2012). Second highest differential regulated gene was Ppp1r3b. Ppp1r3b has been 
described so far only in liver cell, and has been shown to be upregulated in a lymphoid tissue 
of autoimmune mice (Zhu et al. 1993). Ppp1r3b codes for GSK3 targeting catalytic unit of 
protein phosphatase 1 (PP1). PP1 activates glycogen synthase kinase (GSK3) by 
dephosphorylation.  PP1. It plays a major role in regulation of number of enzymes involved in 
glycogen synthesis, glucose and triglyceride metabolism (Ceulemans and Bollen 2004; 
Zhang et al. 2014). Moreover GSK3 has been shown to inhibit T-bet function and upregulate 
PD1 expression in CD8 T cells (Taylor et al. 2016), introducing possibility that Twist1 
promotes PD1 phenotype by stabilizing GSK3 via Ppp1r3b upre ulation. Also, interactions 
between Twist1 and its functional co-factors are controlled by GSK3 mediated 
phosphorylation during tumor progression (Lander et al. 2013). Thus Twist1 mediated 
regulation of Ppp1r3b might be mechanism to support dimerization of Twist1 with its 
functional partners. Twist1 also upregulates Activating transcription factor 5 (ATF5) that 
promotes mitochondrial function and recovery from mitochondrial stress (Fiorese et al. 2016).   
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Glut3 and Glut1 code for proteins mediating a glucose uptake in T cells (Gerriets et al. 2015) 
and Oxct1, PAISC and Gpt2 genes code for proteins involved in synthesis of biomolecules.  
Oxt1 catalyse the formation of Acetoacetyl-CoA, which is a critical metabolite for formation of 
cholesterol, lipid and short-chain acyl-CoAs (MacDonald et al. 2009). PAICS (ADE2) is a 
synthase involved in production of purines in a pentose hosphate pathway, involved in 
proliferation and metastasis of prostate cancer (Chakravarthi et al. 2017). Gpt2 is a 
transaminase located in mitochondria catalysing the generation of pyruvate and glutamate, 
therefore being essential in TCA anaplerosis, crucial feature for synthesis of fatty acids 
(Ouyang et al. 2016).Number of differentially regulated genes by Twist1 is involved in 
scavenging intracellular reactive oxygen. Gpx4 odes f r a NAPDH dependent peroxidase, 
catalyzing oxidation of reduced glutathione by lipid peroxide, major intracellular lipid peroxide 
scavenger. Rdh11 codes for a NADPH-dependent retinal reductase, playing a role in 
regulation of oxidative stress, exhibits an oxido eductive catalytic activity and is involved in 
the metabolism of lipid peroxide derived - short-chain aldehydes (Kasus-Jacobi et al. 2003). 
Last, we observed single downregulation of master transcription factor of glycolysis Myc 
(Wang et al. 2011), which might be molecular background of Twist1 mediated 
downregulation of glycolysis observed in Seahor e studies. Moreover, co-upregulation of 
genes coding for proteins involved in glucose uptake with genes involved in synthesis of 
biomass (purines, fatty acids and triglycerides) suggest involvement of Twist1 in activation 
induced anaplerosis, that is essential for survival of memory T cells (Cui et al. 2015). 
Therefore, Twist1 might contribute to metabolic mechanism supporting memory – futility. 
Futility is simultaneous process of intracellularly synthesis of fatty acids and its oxidation 
(Weinberg and Chandel 2014), utilizing glucose and amino acids from extracellular 
environment (Weinberg and Chandel 2014). While futility is well studied in adipose and 
muscle tissue (Dulloo et al. 2004), and newly discovered in memory CD8 T cells (Weinberg 
and Chandel 2014) mechanism that overpass mutually inhibiting FAO vs. FAS model 
described in effector T cells needs to be explored. The answer should require studying 
localization and levels of Malonyl-CoA in different subpopulations and states, and 
determining the thresholds inhibiting or allowing function of CPT1. 
In summary, based on herewith described transcriptional analysis Twist1 supports synthesis 
of lipids during activation, which might be mechanism related to the survival adaptation of a 
cell to its nutrient limiting environment. It is also possible that Twist1 plays an alternative 
protective function – inhibition of B cell instruc , whi h is pathogenic within synovial 
environment. 
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4.6 Role of Twist1 in fatty acid metabolism   
Affymetrix analysis suggested Twist1 role in build-up of fatty acid storage during activation 
and protection against ROS (Figure 2-15). 24 hours after activation, we observed slightly 
higher lipid content in Twist1 wild-type cells, nevertheless the difference with Twist1- 
deficient cells was not significant (Figure 2-16a). However, later time points after activation 
need to be measured. In order to test functionally possible lack of fatty acids in a long term 
survival, we inhibited glycolysis and glutamin  as a two major energy producing 
alternative pathways to fatty acid oxidation. We hypothesized that the cell will be forced to 
utilize maximum of fatty acids to suffice its energy demands. As showed in (Figure 2-16b), in 
contrast to three time stimulated WT cells, three times stimulated Twist1 deficient cells are 
not capable to survive on fatty acid oxidation. Taken together, even if the molecular 
mechanism remains elusive, Twist1 is essential for repeatedly stimulated Th1 cell to survive  
on fatty acids, possible because of its instruction to build-up of lipid storage during activation, 
that is used to supply energy for a long term homeostatic survival. 
Lipid peroxidation has been previously indicated as a potent factor in pathogenesis of 
rheumatoid arthritis (Seven et al. 2008), where it might mediates antigen presentation, cross 
presentation and release (Dingjan et al. 2016). Therefore, we aimed our investigation 
towards protection of the cell against oxidativspecies tha are formed during oxidative 
metabolism. It was published previously that Etomoxir treatment induces lowering levels of 
NAPDH and subsequent increase of ROS (Pike et al. 2011; Estan et al. 2014), in spite to the 
fact that main OXPHOS source, fatty acid oxidation, s inhibited. We confirmed Etomoxir 
mediated increase of ROS in Figure 2-17. Etomoxir treatment induced high levels of 
superoxides and lipid peroxides 24h after activation. In a contraction phase (192 hour after 
activation) high levels of lipid peroxides were observe specif cally in three times stimulated 
T cells. Twist1 deficient cells were observed to have higher l vels of lipid peroxides than 
their WT counterparts (Figure 2-18). We hypothesized that because of downregulation of 
Gpx4 mRNA in Twist1 deficient cells, Twist1 deficient cells would be sensitive to lipid 
peroxidation. We asked if Etomoxir treatment, causing lipid peroxidation, will affect survival 
of once and repeatedly stimulated Twist1 deficient cells? We normalized their survival to the 
control wt cell. Once stimulated Twist1 deficient Th1 cells treated with Etomoxir were 
hampered in survival 3 days after activation in con rast to WT cells, nevertheless cells were 
capable of recovery:  7 days after activation, Twist1 deficient cells treated with Etomoxir had 
equal survival rate comparable to cells treated with control medium (Figure 2-19).  
Higher survival rates of Twist1 deficient once stimulated Th1 cells 3 days after activation 
reflect importance of glycolysis in activation state and as we have shown, Twist1 
downregulates glycolysis. Etomoxir treatment abrogated glycolysis in effector T cells (Figure 
Discussion 
 
80 
 
2-20a). This indicates that while Twist1 deficiency might affect slightly survival of once 
stimulated Th1 cells long term, fatty acid oxida ion or synthesis does not appear to play a 
role in a long term survival. 
In contrast Etomoxir treatment did not affect glycolysis of repeatedly stimulated Twist WT or 
deficient Th1 cells (Figure 2-20b). Survival was slightly, but insignificantly affected 3 days 
after stimulation (Figure 2-19). Nevertheless, the long-term survival was significantly 
hampered in Twist1 deficient cells on day 7 after activation in both control and fatty acid 
oxidation limiting condition. However, fatty acid inhibition was affecting Twist1 mediated 
survival significantly more that control treated cells (Figure 2-19, squared). We did not 
observe this effect in repeatedly stimulated Th17 cells, suggesting it is Th1 specific (Figure 
2-21). We observed higher lipid peroxidation on day 8 after activation in three time 
stimulated Twist1 deficient cells treated with Etomoxir (Figure 2-18), nevertheless whether it 
is due to defective protection against lipid peroxides needs to be further determined by 
employing Ferroptosis (death cause by high levels of peroxidation) inhibition by small 
molecules, such as Ferrostatin or complementation study, such as overexpression of Gpx4. 
4.7 Conclusions and outlook 
 
In this thesis, for the first time, we study the metabolism of rheumatoid Th1 cells. It was 
shown previously, that naive cells isolated from RA patient   do not metabolically meet 
activation-imposed energy demands as they fail to induce  the glycolytic enzyme 
6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase 3 (PFKFB3). This causes 
accumulation of glucose-6 phosphate (G6P) resulting in increased shuffle of G6P to the 
pentose phosphate pathway.  By action of glucose 6 phosphate dehydrogenase (G6PD) 
accumulated G6P is converted to ribulose 5 phosphate and NAPDH. As a major factor in 
ROS scavenging, overproduction of NAPD leads to the downregulation of ROS mediated cell 
signalling, leading to hyper proliferation of T hel e  cells (Yang et al. 2016). This study, 
however, omits influence of stimulation history and synovial environment. Study by Yang et 
al. goes in line with our findings: NAPDH overproduction  might support accumulation of 
newly formed fatty acids in rheumatic cells. Increased production of lipid intracellular content 
would give these CD4+ T cells big survival advantage, as oxidation of fatty acids is most 
efficient energy pathways. Here, we show that in vitro repeatedly stimulated murine T cells 
and human pathogenic T cells isolated ex vivo from the site of inflammation of patients 
suffering from JIA are more reliant on fatty acid oxidation than on glycolysis. Our experiment 
shows that CD45RO CD4 CXCR5- PD1+, marked as pathogenic cells in inflamed synovium, 
had higher survival rates than CD45RO CD4 CXCR5- PD1- synovial cells. We also show that 
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CD45RO CD4 CXCR5- PD1+ cells can be selectively starved in vitro by inhibition of fatty 
acid oxidation. Additionally, we show that CD45RO CD4 CXCR5- PD1+ synovial cells have 
upregulated Twist1 that supports de novo synthesis of fatty acids and protection against 
oxygen reactive species. Fatty acids are perfect w y to sto e an energy: triacylglycerol (TAG) 
can be produced from both carbohydrates and amino acids and be utilized in times during 
starvation. Is the metabolism of pathogenic cells promising target for treatment? So far, 
attempts for treatment of Th1 driven chronic inflammation involve blockage of pro-
inflammatory cytokines such as TNF-α or IL-6 receptor and lead to amelioration of 
inflammation (Skurkovich et al. 2001; Ryan et al. 2010). Nevertheless, upon withdrawal of 
treatment, symptoms relapse. Alternative, symptoms relieving, strategy in patients with 
rheumatoid arthritis is immunoablation of all CD4 + T cells. Sadly, cap city of immune system 
to fight against pathogens and opportunistic infections is lowered (Horneff et al. 1991; Brett 
et al. 1996; Choy et al. ; Emmrich et al.), likely because of depletion efficiency was observed 
higher in the naive circulating and protective T helper and Treg pool than in the (auto-) 
antigen experienced memory Th1 cells (Horneff et al.). Complete ablation of immune system 
followed by autologous stem cell transplanta ion (ASCT) (Muraro and Abrahamsson ; 
Alexander et al. ; LoCascio et al. ; Couri et al.) has been another attempt of treatment where 
it was possible to establish  novel immune system with a long-term remission in most 
patients. However, invasive, complicated nature of the treatment bears risks for patients such 
as therapy-associated lymphopenia opening window for opportunistic bacterial and fungal 
infections, development of de novo aut immunity and malignancies in the first years after 
ASCT (Daikeler et al. ; Holbro et al. ; Marmont ; Couri et al.). Therefore search for novel, 
non-invasive therapies is still of high interest and our findings on the metabolism of 
pathogenic immune response hint potential development of new drugs that are able to inhibit 
selectively metabolic pathways. Utilizing metabolic properties to target pathogenic 
mechanisms of RA is attractive, in particular since metabolic inhibitors treatment is used in 
treatment of heart failure, diabetes or cancer (Rupp et al. 2002; Giannessi et al. 2003; 
Camarda et al. 2016).  
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Supplementary Table 
Table 4 Genes differentially expressed in repeatedly stimulated Th1 Twist wt/wt versus 
repeatedly stimulated Th1 Twist fl/fl 
The transcriptional profiles of duplicates of cultures were compared using Affymetrix Murine 
Genome GeneChip arrays. The Affymetrix probe set ID (Affymetr_No),Gene Symbol, Name, 
Mean Affymetrix Signal, fold change,HPCDA (High Performance Chip Data Analysis) score 
two arrays per group are shown. Genes were filtered according to the following criteria: fold 
change >= 1,1; probe signal in wt >= 120; excluding immunoglobulin genes, relational data 
base for data analysis was created by Joachim Gruen, DRFZ, Berlin). 
 
Affymetrix  
Number 
Gene 
Symbol 
Name Mean_ 
Signal  
Twist wt/wt 
Mean_ 
Signal 
Twist1 fl/fl 
FC HPCDA 
Score 
1418733_at Twist1 twist gene homolog 1 
(Drosophila) 
1282.25 203.25 5.66 355.47 
1423466_at Ccr7 chemokine (C-C motif) 
receptor 7 
370 126.85 2.78 170.50 
1422470_at Bnip3 BCL2/adenovirus E1B 
interacting protein 1, 
NIP3 
722.65 439 1.80 177.42 
1438239_at Mid1 midline 1 821.45 539.25 1.74 198.66 
1436590_at Ppp1r3b protein phosphatase 1, 
regulatory (inhibitor) 
subunit 3B 
291.6 177.55 1.68 183.82 
1420425_at Prdm1 PR domain containing 
1, with ZNF domain 
238.6 165.85 1.60 210.20 
1423747_a_at Pdk1 pyruvate 
dehydrogenase 
kinase, isoenzyme 1 
377.5 226.4 1.57 174.04 
1436990_s_at Ndg2 Nur77 downstream 
gene 2 
626.05 499.85 1.54 192.68 
1453556_x_at Cd99 CD99 antigen 287.4 165.65 1.54 199.00 
1454109_a_at Jmjd6 jumonji domain 
containing 6 
295.3 208.4 1.52 205.34 
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1418188_a_at Malat1 Metastasis associated 
lung adenocarcinoma 
transcript 1 (non-
coding RNA) 
770.8 473.5 1.49 177.49 
1417546_at Il2rb interleukin 2 receptor, 
beta chain 
323.85 210.35 1.46 188.84 
1438504_x_at Tm7sf3 Transmembrane 7 
superfamily member 3 
144.7 76 1.46 236.51 
1450981_at Cnn2 calponin 2 466.6 300.7 1.46 190.68 
1425927_a_at Atf5 activating transcription 
factor 5 
317.5 238.1 1.44 173.20 
1427532_at Trat1 T cell receptor 
associated 
transmembrane 
adaptor 1 
200.2 138.9 1.44 223.87 
1451695_a_at Gpx4 glutathione peroxidase 
4 
716.45 516.1 1.44 175.88 
1421855_at Fgl2 fibrinogen-like protein 
2 
46.55 26.35 1.41 236.28 
1422716_a_at Acp1 acid phosphatase 1, 
soluble 
188.75 125.15 1.41 202.21 
1430634_a_at Pfkp phosphofructokinase, 
platelet 
147.55 95.9 1.41 219.58 
1437052_s_at Slc2a3 solute carrier family 2 
(facilitated glucose 
transporter), member 3
5269.75 3946.8 1.41 238.34 
1450749_a_at Nr4a2 nuclear receptor 
subfamily 4, group A, 
member 2 
876.1 680.6 1.37 207.26 
1434773_a_at Slc2a1 solute carrier family 2 
(facilitated glucose 
transporter), member 1
2946.05 2251.1 1.34 191.30 
1423423_at Pdia3 protein disulfide 
isomerase associated 
3 
2495.45 1827.6 1.32 228.40 
1436750_a_at Oxct1 3-oxoacid CoA 
transferase 1 
334.35 240.05 1.32 173.19 
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1453622_s_at Mllt3 myeloid/lymphoid or 
mixed lineage-
leukemia translocation 
to 3 homolog 
(Drosophila) 
243.4 171.55 1.32 198.50 
1418760_at Rdh11 retinol dehydrogenase 
11 
289.05 211.15 1.30 213.23 
1423548_s_at Ergic3 ERGIC and golgi 3 374.95 282.55 1.30 173.43 
1416246_a_at Coro1a coronin, actin binding 
protein 1A 
2973.65 2341.85 1.27 190.39 
1438366_x_at Clcn3 chloride channel 3 552.3 403.5 1.27 187.50 
1450696_at Psmb9 proteasome (prosome, 
macropain) subunit, 
beta type 9 (large 
multifunctional 
peptidase 2) 
616.25 484.85 1.27 174.70 
1455007_s_at Gpt2 glutamic pyruvate 
transaminase (alanine 
aminotransferase) 2 
372.85 313.85 1.27 184.56 
1422280_at Gzmk granzyme K 498.05 369.6 1.25 210.51 
1451081_a_at Tcf25 transcription factor 25 
(basic helix-loop-helix) 
261 219.45 1.25 189.55 
1457120_at Itk IL2-inducible T-cell 
kinase 
1120.4 945.7 1.25 177.49 
1460469_at Tnfrsf9 tumor necrosis factor 
receptor superfamily, 
member 9 
2662.35 2010.95 1.25 204.50 
1437249_at Skap1 src family associated 
phosphoprotein 1 
490.65 378.65 1.23 173.75 
1436298_x_at Paics phosphoribosylaminoi
midazole carboxylase, 
phosphoribosylaminori
bosylaminoimidazole, 
succinocarboxamide 
synthetase 
1748.05 1205.95 1.19 200.49 
1436152_a_at Hbxip hepatitis B virus x 
interacting protein 
1654.85 1325.8 1.17 229.19 
1429005_at Mfhas1 malignant fibrous 1514 1777.75 -1.21 212.06 
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histiocytoma amplified 
sequence 1 
1437690_x_at Csnk1d casein kinase 1, delta 609.4 744.9 -1.21 222.16 
1450330_at Il10 interleukin 10 5822.35 6841.85 -1.21 236.39 
1448898_at Ccl9 chemokine (C-C motif) 
ligand 9 
3208.9 3962.5 -1.23 263.27 
1416755_at Dnajb1 DnaJ (Hsp40) 
homolog, subfamily B, 
member 1 
560.85 706.3 -1.25 175.52 
1421930_at Icos  inducible T-cell co-
stimulator /// similar to 
activation-inducible 
lymphocyte 
immunomediatory 
molecule AILIM 
1275.5 1701.4 -1.25 222.31 
1422924_at Tnfsf9 tumor necrosis factor 
(ligand) superfamily, 
member 9 
2554.35 3196.1 -1.25 191.17 
1434674_at Lyst lysosomal trafficking 
regulator 
384.95 499.3 -1.25 197.33 
1435557_at Fhod1 formin homology 2 
domain containing 1 
149.8 198.55 -1.25 205.96 
1451596_a_at Sphk1 sphingosine kinase 1 980.55 1284.65 -1.25 179.33 
1452214_at Skil SKI-like 827.65 1168.8 -1.25 179.61 
1416083_at Za20d2 zinc finger, AN1-type 
domain 5 /// similar to 
zinc finger protein 
ZNF216 
926.45 1170.3 -1.27 199.95 
1416926_at Trp53in
p1 
tra sformation related 
protein 53 inducible 
nuclear protein 1 
1744.2 2348.8 -1.27 187.59 
1420965_a_at Enc1 ectodermal-neural 
cortex 1 
456.65 583.4 -1.27 183.54 
1425745_a_at Tacc2 transforming, acidic 
coiled-coil containing 
protein 2 
618.3 772.1 -1.27 175.53 
1449235_at Fasl Fas ligand (TNF 
superfamily, member 
1406.9 1734.35 -1.27 196.84 
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6) 
1452406_x_at Erdr1 erythroid differentiation 
regulator 1 
2894.05 3552.5 -1.27 212.94 
1419208_at Map3k8 mitogen activated 
protein kinase kinase 
kinase 8 
1591.9 1913.2 -1.30 181.82 
1424090_at Sdcbp2 syndecan binding 
protein (syntenin) 2 
317.85 423.1 -1.30 180.97 
1418926_at Zeb1 zinc finger E-box 
binding homeobox 1 
391.45 488.25 -1.32 766.63 
1420895_at Tgfbr1 transforming growth 
factor, beta receptor I 
245.25 305.1 -1.32 194.08 
1424942_a_at Myc myelocytomatosis 
oncogene 
4093.45 5184.6 -1.32 245.99 
1426334_a_at Bcl2l11 BCL2-like 11 
(apoptosis facilitator) 
173.9 225 -1.34 172.59 
1433451_at Cdk5r1 cyclin-dependent 
kinase 5, regulatory 
subunit (p35) 1 
333.85 624 -1.34 176.82 
1422567_at Niban niban protein 1019.15 1364.05 -1.37 876.54 
1434129_s_at Lhfpl2 lipoma HMGIC fusion 
partner-like 2 
105.1 153.9 -1.41 203.12 
1450334_at Il21  interleukin 21 /// similar 
to interleukin 21 
1489.55 2193.65 -1.44 224.51 
1456700_x_at Marcks myristoylated alanine 
rich protein kinase C 
substrate 
120.1 222.95 -1.49 173.05 
1430001_at Il31 interleukin 31 290.55 486.05 -1.52 174.96 
1427256_at Vcan versican 422.35 666.25 -1.62 205.80 
1427624_s_at Il22 /// 
Iltifb 
interleukin 22 /// 
interleukin 10-related T 
cell-derived inducible 
factor beta 
103.65 198.85 -2.14 197.69 
1417256_at Mmp13 matrix 
metallopeptidase 13 
146.65 368.7 -2.18 591.79 
1426438_at Ddx3y DEAD (Asp-Glu-Ala-
Asp) box polypeptide 
123.85 561.15 -
17.4
380.52 
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